HUE035332T2 - 1H-pirrollo[2,3-b]piridin-származékok, valamint ezek kináz-inhibitorokként való alkalmazása - Google Patents
1H-pirrollo[2,3-b]piridin-származékok, valamint ezek kináz-inhibitorokként való alkalmazása Download PDFInfo
- Publication number
- HUE035332T2 HUE035332T2 HUE13703121A HUE13703121A HUE035332T2 HU E035332 T2 HUE035332 T2 HU E035332T2 HU E13703121 A HUE13703121 A HU E13703121A HU E13703121 A HUE13703121 A HU E13703121A HU E035332 T2 HUE035332 T2 HU E035332T2
- Authority
- HU
- Hungary
- Prior art keywords
- pyrrolo
- pyridin
- benzyl
- pyrazole
- amide
- Prior art date
Links
- 150000005258 1H-pyrrolo(2,3-b)pyridines Chemical class 0.000 title description 4
- 229940043355 kinase inhibitor Drugs 0.000 title 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims description 343
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 107
- -1 mercapto, mercapto Chemical class 0.000 claims description 71
- 239000000203 mixture Substances 0.000 claims description 69
- 238000000034 method Methods 0.000 claims description 59
- NQRYJNQNLNOLGT-UHFFFAOYSA-N tetrahydropyridine hydrochloride Natural products C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 31
- 229910052736 halogen Inorganic materials 0.000 claims description 27
- 125000000623 heterocyclic group Chemical group 0.000 claims description 27
- 150000002367 halogens Chemical class 0.000 claims description 26
- 125000000217 alkyl group Chemical group 0.000 claims description 25
- 206010028980 Neoplasm Diseases 0.000 claims description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 20
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 20
- 150000003839 salts Chemical class 0.000 claims description 19
- 125000001072 heteroaryl group Chemical group 0.000 claims description 18
- 125000003107 substituted aryl group Chemical group 0.000 claims description 18
- 201000011510 cancer Diseases 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 14
- 239000002253 acid Substances 0.000 claims description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 13
- 125000001424 substituent group Chemical group 0.000 claims description 13
- 238000011282 treatment Methods 0.000 claims description 11
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 10
- 125000003118 aryl group Chemical group 0.000 claims description 10
- 239000001257 hydrogen Substances 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 10
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical class C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims description 7
- 125000005346 substituted cycloalkyl group Chemical group 0.000 claims description 7
- 125000003545 alkoxy group Chemical group 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 125000004450 alkenylene group Chemical group 0.000 claims description 5
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 5
- 239000008194 pharmaceutical composition Substances 0.000 claims description 5
- 125000004193 piperazinyl group Chemical group 0.000 claims description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 5
- 238000002560 therapeutic procedure Methods 0.000 claims description 5
- 125000002947 alkylene group Chemical group 0.000 claims description 4
- 125000000732 arylene group Chemical group 0.000 claims description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 4
- 229910052794 bromium Inorganic materials 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- 125000005549 heteroarylene group Chemical group 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- 125000005717 substituted cycloalkylene group Chemical group 0.000 claims description 4
- 208000023275 Autoimmune disease Diseases 0.000 claims description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 3
- 150000002431 hydrogen Chemical class 0.000 claims description 3
- 150000003053 piperidines Chemical class 0.000 claims description 3
- 229910006074 SO2NH2 Inorganic materials 0.000 claims description 2
- 239000011230 binding agent Substances 0.000 claims description 2
- 238000002512 chemotherapy Methods 0.000 claims description 2
- 230000006378 damage Effects 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 150000001408 amides Chemical class 0.000 claims 11
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 10
- IMBBXSASDSZJSX-UHFFFAOYSA-N 4-Carboxypyrazole Chemical compound OC(=O)C=1C=NNC=1 IMBBXSASDSZJSX-UHFFFAOYSA-N 0.000 claims 3
- WNZQDUSMALZDQF-UHFFFAOYSA-N 2-benzofuran-1(3H)-one Chemical class C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 claims 2
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 150000001735 carboxylic acids Chemical class 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 125000006710 (C2-C12) alkenyl group Chemical group 0.000 claims 1
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 claims 1
- UZEFHQIOSJWWSB-UHFFFAOYSA-N 4-azidobenzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=C(N=[N+]=[N-])C=C1 UZEFHQIOSJWWSB-UHFFFAOYSA-N 0.000 claims 1
- 125000004176 4-fluorobenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1F)C([H])([H])* 0.000 claims 1
- 101100439253 Arabidopsis thaliana CHI3 gene Proteins 0.000 claims 1
- 241000726103 Atta Species 0.000 claims 1
- 101100087530 Caenorhabditis elegans rom-1 gene Proteins 0.000 claims 1
- 101100426970 Caenorhabditis elegans ttr-1 gene Proteins 0.000 claims 1
- QXKAIJAYHKCRRA-JJYYJPOSSA-N D-arabinonic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(O)=O QXKAIJAYHKCRRA-JJYYJPOSSA-N 0.000 claims 1
- 101100456896 Drosophila melanogaster metl gene Proteins 0.000 claims 1
- 241000196324 Embryophyta Species 0.000 claims 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 claims 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 claims 1
- 235000010044 Hernandia moerenhoutiana Nutrition 0.000 claims 1
- 244000084296 Hernandia moerenhoutiana Species 0.000 claims 1
- 101100305983 Mus musculus Rom1 gene Proteins 0.000 claims 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 1
- QPFYXYFORQJZEC-FOCLMDBBSA-N Phenazopyridine Chemical compound NC1=NC(N)=CC=C1\N=N\C1=CC=CC=C1 QPFYXYFORQJZEC-FOCLMDBBSA-N 0.000 claims 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 claims 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 claims 1
- 101100097319 Schizosaccharomyces pombe (strain 972 / ATCC 24843) ala1 gene Proteins 0.000 claims 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 claims 1
- 244000250129 Trigonella foenum graecum Species 0.000 claims 1
- 230000002730 additional effect Effects 0.000 claims 1
- 125000006323 alkenyl amino group Chemical group 0.000 claims 1
- 125000005002 aryl methyl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 210000004556 brain Anatomy 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 claims 1
- 150000007942 carboxylates Chemical class 0.000 claims 1
- 125000003963 dichloro group Chemical group Cl* 0.000 claims 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims 1
- ZNNLBTZKUZBEKO-UHFFFAOYSA-N glyburide Chemical compound COC1=CC=C(Cl)C=C1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1 ZNNLBTZKUZBEKO-UHFFFAOYSA-N 0.000 claims 1
- 230000003394 haemopoietic effect Effects 0.000 claims 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 claims 1
- HZVOZRGWRWCICA-UHFFFAOYSA-N methanediyl Chemical compound [CH2] HZVOZRGWRWCICA-UHFFFAOYSA-N 0.000 claims 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 claims 1
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 1
- 125000006504 o-cyanobenzyl group Chemical group [H]C1=C([H])C(C#N)=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims 1
- LWMPFIOTEAXAGV-UHFFFAOYSA-N piperidin-1-amine Chemical compound NN1CCCCC1 LWMPFIOTEAXAGV-UHFFFAOYSA-N 0.000 claims 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 claims 1
- WHYQCQRHPQBZHM-UHFFFAOYSA-N pyrazole-1-carboxylic acid Chemical compound OC(=O)N1C=CC=N1 WHYQCQRHPQBZHM-UHFFFAOYSA-N 0.000 claims 1
- 229940070891 pyridium Drugs 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 108010036387 trimethionine Proteins 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 308
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 276
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 200
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 140
- 239000007787 solid Substances 0.000 description 121
- 229910001868 water Inorganic materials 0.000 description 112
- AFABGHUZZDYHJO-UHFFFAOYSA-N 2-Methylpentane Chemical compound CCCC(C)C AFABGHUZZDYHJO-UHFFFAOYSA-N 0.000 description 108
- 238000002360 preparation method Methods 0.000 description 105
- 235000019439 ethyl acetate Nutrition 0.000 description 100
- 239000000243 solution Substances 0.000 description 99
- 238000005160 1H NMR spectroscopy Methods 0.000 description 97
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 97
- 229920006395 saturated elastomer Polymers 0.000 description 95
- 238000006243 chemical reaction Methods 0.000 description 84
- KGDOHXYALMXHLF-UHFFFAOYSA-N 1-benzylpyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1CC1=CC=CC=C1 KGDOHXYALMXHLF-UHFFFAOYSA-N 0.000 description 74
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 74
- 239000011541 reaction mixture Substances 0.000 description 71
- 239000011780 sodium chloride Substances 0.000 description 70
- 239000002904 solvent Substances 0.000 description 64
- 239000000047 product Substances 0.000 description 63
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 54
- 238000004440 column chromatography Methods 0.000 description 52
- 239000013058 crude material Substances 0.000 description 49
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 41
- 239000000843 powder Substances 0.000 description 37
- 238000007792 addition Methods 0.000 description 30
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 28
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 26
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 26
- 229910000027 potassium carbonate Inorganic materials 0.000 description 26
- AKKPGUPOFLAXRN-UHFFFAOYSA-N 1-[(4-fluorophenyl)methyl]pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1CC1=CC=C(F)C=C1 AKKPGUPOFLAXRN-UHFFFAOYSA-N 0.000 description 24
- 238000001914 filtration Methods 0.000 description 23
- 239000000463 material Substances 0.000 description 23
- 239000003921 oil Substances 0.000 description 23
- 235000019198 oils Nutrition 0.000 description 23
- 238000003756 stirring Methods 0.000 description 22
- 239000006071 cream Substances 0.000 description 21
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Substances [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 21
- 239000000284 extract Substances 0.000 description 20
- 238000003818 flash chromatography Methods 0.000 description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 18
- 238000002953 preparative HPLC Methods 0.000 description 18
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 17
- 238000000746 purification Methods 0.000 description 17
- RWRDLPDLKQPQOW-UHFFFAOYSA-N tetrahydropyrrole Natural products C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 16
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 15
- 102000006459 Checkpoint Kinase 1 Human genes 0.000 description 14
- 108010019244 Checkpoint Kinase 1 Proteins 0.000 description 14
- 239000012044 organic layer Substances 0.000 description 14
- LGRLJNBPDMHSOL-UHFFFAOYSA-N 1-benzyl-n-[5-bromo-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C2=NC=C(Br)C=C2C(NC(=O)C2=CN(CC=3C=CC=CC=3)N=C2)=C1 LGRLJNBPDMHSOL-UHFFFAOYSA-N 0.000 description 13
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 13
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical class [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 13
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 13
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 13
- 235000011114 ammonium hydroxide Nutrition 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 13
- WUOQXNWMYLFAHT-MRVPVSSYSA-N tert-butyl n-[(3r)-piperidin-3-yl]carbamate Chemical compound CC(C)(C)OC(=O)N[C@@H]1CCCNC1 WUOQXNWMYLFAHT-MRVPVSSYSA-N 0.000 description 13
- UORKPBOZTFYKBG-UHFFFAOYSA-N 1-benzyl-n-(5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C12=CC(Br)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC=C1 UORKPBOZTFYKBG-UHFFFAOYSA-N 0.000 description 12
- JMCVFWQJWKRMHW-UHFFFAOYSA-N 5-bromo-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C(Br)C=C2C(N)=CNC2=N1 JMCVFWQJWKRMHW-UHFFFAOYSA-N 0.000 description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- RJAFVJZCUMEOBR-UHFFFAOYSA-N 1-(pyridin-4-ylmethyl)pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1CC1=CC=NC=C1 RJAFVJZCUMEOBR-UHFFFAOYSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 11
- 238000005516 engineering process Methods 0.000 description 11
- 238000010438 heat treatment Methods 0.000 description 11
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 11
- 239000003112 inhibitor Substances 0.000 description 11
- 239000000725 suspension Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- GNRWXAUPOYGSJF-MRVPVSSYSA-N 4-[(3R)-3-aminopiperidin-1-yl]-5-methoxy-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound COC1=CN=C2NC=C(N)C2=C1N1CCC[C@@H](N)C1 GNRWXAUPOYGSJF-MRVPVSSYSA-N 0.000 description 10
- 241000400611 Eucalyptus deanei Species 0.000 description 10
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 10
- 238000003556 assay Methods 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 10
- WCMWZVWZYCRAIW-UHFFFAOYSA-N 1-(pyridin-3-ylmethyl)pyrazole-4-carboxylic acid Chemical group C1=C(C(=O)O)C=NN1CC1=CC=CN=C1 WCMWZVWZYCRAIW-UHFFFAOYSA-N 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 9
- 239000007821 HATU Substances 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 9
- 239000011521 glass Substances 0.000 description 9
- 238000005342 ion exchange Methods 0.000 description 9
- 235000011121 sodium hydroxide Nutrition 0.000 description 9
- LCTSAPFWCLXWNS-HXUWFJFHSA-N tert-butyl n-[(3r)-1-[3-[(1-benzylpyrazole-4-carbonyl)amino]-5-bromo-1h-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl]carbamate Chemical compound C1[C@H](NC(=O)OC(C)(C)C)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 LCTSAPFWCLXWNS-HXUWFJFHSA-N 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 9
- RLIKCTSDMAQFES-UHFFFAOYSA-N 1-benzyl-N-[1-(4-methylphenyl)sulfonyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound Cc1ccc(cc1)S(=O)(=O)n1cc(NC(=O)c2cnn(Cc3ccccc3)c2)c2cc(cnc12)B1OC(C)(C)C(C)(C)O1 RLIKCTSDMAQFES-UHFFFAOYSA-N 0.000 description 8
- TYOAKDISSULLGZ-SSDOTTSWSA-N 4-[(3R)-3-aminopiperidin-1-yl]-5-bromo-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1[C@H](N)CCCN1C1=C(Br)C=NC2=C1C(N)=CN2 TYOAKDISSULLGZ-SSDOTTSWSA-N 0.000 description 8
- WPZRLMSKIZPOBF-UHFFFAOYSA-N 5-chloro-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C(Cl)C=C2C(N)=CNC2=N1 WPZRLMSKIZPOBF-UHFFFAOYSA-N 0.000 description 8
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical class C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 8
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 8
- 235000019270 ammonium chloride Nutrition 0.000 description 8
- 101150113535 chek1 gene Proteins 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- 230000002829 reductive effect Effects 0.000 description 8
- SOUZKMFQFRDGKE-UHFFFAOYSA-N 1-(pyridin-2-ylmethyl)pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1CC1=CC=CC=N1 SOUZKMFQFRDGKE-UHFFFAOYSA-N 0.000 description 7
- PUJVSTYUTMVCSG-UHFFFAOYSA-N 5-bromo-4-fluoro-1h-pyrrolo[2,3-b]pyridine Chemical compound FC1=C(Br)C=NC2=C1C=CN2 PUJVSTYUTMVCSG-UHFFFAOYSA-N 0.000 description 7
- 101150050673 CHK1 gene Proteins 0.000 description 7
- 244000166102 Eucalyptus leucoxylon Species 0.000 description 7
- 235000004694 Eucalyptus leucoxylon Nutrition 0.000 description 7
- HLZOIFAAAWCMOG-UHFFFAOYSA-N Fc1c(Br)cnc2[nH]cc(NC(=O)c3cnn(Cc4ccccc4)c3)c12 Chemical compound Fc1c(Br)cnc2[nH]cc(NC(=O)c3cnn(Cc4ccccc4)c3)c12 HLZOIFAAAWCMOG-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000012065 filter cake Substances 0.000 description 7
- 229960005277 gemcitabine Drugs 0.000 description 7
- 239000012074 organic phase Substances 0.000 description 7
- ROSDSFDQCJNGOL-UHFFFAOYSA-N protonated dimethyl amine Natural products CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 7
- 238000002877 time resolved fluorescence resonance energy transfer Methods 0.000 description 7
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 7
- 238000001665 trituration Methods 0.000 description 7
- 238000010626 work up procedure Methods 0.000 description 7
- HJBGZJMKTOMQRR-UHFFFAOYSA-N (3-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=CC(C=O)=C1 HJBGZJMKTOMQRR-UHFFFAOYSA-N 0.000 description 6
- GUYKTJJGCNDECQ-NEPJUHHUSA-N (3R,4R)-4-cyclopropyl-N-diethoxyphosphorylpiperidin-3-amine Chemical compound CCOP(=O)(OCC)N[C@H]1CNCC[C@@H]1C1CC1 GUYKTJJGCNDECQ-NEPJUHHUSA-N 0.000 description 6
- YESANHMKGXGZLQ-UHFFFAOYSA-N (4-fluoropyrrolo[2,3-b]pyridin-1-yl)-tri(propan-2-yl)silane Chemical compound C1=CN=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1F YESANHMKGXGZLQ-UHFFFAOYSA-N 0.000 description 6
- OETDPVHIOQFDBI-UHFFFAOYSA-N 1-benzyl-n-(4-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C1=2C(Br)=CC=NC=2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC=C1 OETDPVHIOQFDBI-UHFFFAOYSA-N 0.000 description 6
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 6
- GRAATXNNMKWDDS-SSDOTTSWSA-N N[C@@H]1CCCN(C1)c1c(Cl)cnc2[nH]cc(N)c12 Chemical compound N[C@@H]1CCCN(C1)c1c(Cl)cnc2[nH]cc(N)c12 GRAATXNNMKWDDS-SSDOTTSWSA-N 0.000 description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 6
- 239000002246 antineoplastic agent Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 6
- 125000004356 hydroxy functional group Chemical group O* 0.000 description 6
- 239000012321 sodium triacetoxyborohydride Substances 0.000 description 6
- HJUGFYREWKUQJT-UHFFFAOYSA-N tetrabromomethane Chemical compound BrC(Br)(Br)Br HJUGFYREWKUQJT-UHFFFAOYSA-N 0.000 description 6
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 5
- FKVTXXBRIXJUQQ-UHFFFAOYSA-N 1-benzyl-n-[5-[3-(2-morpholin-4-ylethoxy)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CC=CC=1OCCN1CCOCC1 FKVTXXBRIXJUQQ-UHFFFAOYSA-N 0.000 description 5
- XVRJHIDTMLOKPU-UHFFFAOYSA-N 1-benzyl-n-[5-[3-(2-pyrrolidin-1-ylethoxy)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CC=CC=1OCCN1CCCC1 XVRJHIDTMLOKPU-UHFFFAOYSA-N 0.000 description 5
- UEATVVZEWOUJKH-UHFFFAOYSA-N 1-benzyl-n-[5-[3-[(dimethylamino)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound CN(C)CC1=CC=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=C1 UEATVVZEWOUJKH-UHFFFAOYSA-N 0.000 description 5
- ZUOPKGTYJJCCND-UHFFFAOYSA-N 5-bromo-4-fluoro-3-nitro-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C(Br)C(F)=C2C([N+](=O)[O-])=CNC2=N1 ZUOPKGTYJJCCND-UHFFFAOYSA-N 0.000 description 5
- 108091000080 Phosphotransferase Proteins 0.000 description 5
- 239000012043 crude product Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 125000002757 morpholinyl group Chemical group 0.000 description 5
- ABZYQTQZJDCXJQ-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(Cl)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 ABZYQTQZJDCXJQ-QGZVFWFLSA-N 0.000 description 5
- WPIMBSFJUGQKSO-GOSISDBHSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methoxy-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(OC)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC=C1 WPIMBSFJUGQKSO-GOSISDBHSA-N 0.000 description 5
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 5
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 102000020233 phosphotransferase Human genes 0.000 description 5
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 5
- 235000011118 potassium hydroxide Nutrition 0.000 description 5
- GSXCRDCXKUWXJK-UHFFFAOYSA-M potassium;1-(1h-pyrrol-2-ylmethyl)pyrazole-4-carboxylate Chemical group [K+].C1=C(C(=O)[O-])C=NN1CC1=CC=CN1 GSXCRDCXKUWXJK-UHFFFAOYSA-M 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 235000017557 sodium bicarbonate Nutrition 0.000 description 5
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 5
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 5
- ALENDSSETVVANF-LLVKDONJSA-N tert-butyl n-[(3r)-1-(3-amino-5-methoxy-1h-pyrrolo[2,3-b]pyridin-4-yl)piperidin-3-yl]carbamate Chemical compound COC1=CN=C2NC=C(N)C2=C1N1CCC[C@@H](NC(=O)OC(C)(C)C)C1 ALENDSSETVVANF-LLVKDONJSA-N 0.000 description 5
- YMSXGXBENOJJLW-UHFFFAOYSA-N (4-fluoro-3-nitro-1h-pyrrolo[2,3-b]pyridin-5-yl) 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC1=CN=C2NC=C([N+]([O-])=O)C2=C1F YMSXGXBENOJJLW-UHFFFAOYSA-N 0.000 description 4
- ACKKVNVNGUYIAR-UHFFFAOYSA-N 1-[(3-methoxyphenyl)methyl]pyrazole-4-carboxylic acid Chemical compound COC1=CC=CC(CN2N=CC(=C2)C(O)=O)=C1 ACKKVNVNGUYIAR-UHFFFAOYSA-N 0.000 description 4
- IKIIMRKHGIWFEP-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1CC1=CC=C(Cl)C=C1 IKIIMRKHGIWFEP-UHFFFAOYSA-N 0.000 description 4
- GJVFRIBDYISNDD-UHFFFAOYSA-N 1-benzyl-n-(5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C12=CC(Cl)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC=C1 GJVFRIBDYISNDD-UHFFFAOYSA-N 0.000 description 4
- FBLBZRLTZBPZFA-UHFFFAOYSA-N 1-benzyl-n-(5-phenyl-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C1=CC=CC=C1 FBLBZRLTZBPZFA-UHFFFAOYSA-N 0.000 description 4
- MVQKTQBUBSANNZ-UHFFFAOYSA-N 1-benzyl-n-[1-(4-methylphenyl)sulfonyl-5-[3-(2-morpholin-4-ylethoxy)phenyl]pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)N1C2=NC=C(C=3C=C(OCCN4CCOCC4)C=CC=3)C=C2C(NC(=O)C2=CN(CC=3C=CC=CC=3)N=C2)=C1 MVQKTQBUBSANNZ-UHFFFAOYSA-N 0.000 description 4
- XKZWGEUABLHBNY-UHFFFAOYSA-N 1-benzyl-n-[5-(4-formylphenyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=CC(C=O)=CC=C1C1=CN=C(NC=C2NC(=O)C3=CN(CC=4C=CC=CC=4)N=C3)C2=C1 XKZWGEUABLHBNY-UHFFFAOYSA-N 0.000 description 4
- IHPXFCQAPBYVLG-VWLOTQADSA-N 1-benzyl-n-[5-[3-[[(2s)-1-methylpyrrolidin-2-yl]methoxy]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound CN1CCC[C@H]1COC1=CC=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=C1 IHPXFCQAPBYVLG-VWLOTQADSA-N 0.000 description 4
- WQTCAALJJAUNEH-UHFFFAOYSA-N 2-(4-bromopyrazol-1-yl)-n,n-diethylethanamine Chemical compound CCN(CC)CCN1C=C(Br)C=N1 WQTCAALJJAUNEH-UHFFFAOYSA-N 0.000 description 4
- NBJHDLKSWUDGJG-UHFFFAOYSA-N 4-(2-chloroethyl)morpholin-4-ium;chloride Chemical compound Cl.ClCCN1CCOCC1 NBJHDLKSWUDGJG-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- RTADYVMNEDWFEV-SSDOTTSWSA-N 4-[(3R)-3-aminopiperidin-1-yl]-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1[C@H](N)CCCN1C1=C(C(F)(F)F)C=NC2=C1C(N)=CN2 RTADYVMNEDWFEV-SSDOTTSWSA-N 0.000 description 4
- RWOSDAABDCYOQZ-UHFFFAOYSA-N 4-bromo-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=CC(Br)=C2C(N)=CNC2=N1 RWOSDAABDCYOQZ-UHFFFAOYSA-N 0.000 description 4
- LIMWPGZSXIVMIU-UHFFFAOYSA-N 4-fluoro-1-tri(propan-2-yl)silylindol-5-ol Chemical compound OC1=CC=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1F LIMWPGZSXIVMIU-UHFFFAOYSA-N 0.000 description 4
- LPTVWZSQAIDCEB-UHFFFAOYSA-N 5-bromo-1h-pyrrolo[2,3-b]pyridine Chemical compound BrC1=CN=C2NC=CC2=C1 LPTVWZSQAIDCEB-UHFFFAOYSA-N 0.000 description 4
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 description 4
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 4
- 102000010111 Ezrin/radixin/moesin Human genes 0.000 description 4
- 108050001788 Ezrin/radixin/moesin Proteins 0.000 description 4
- 229910017711 NHRa Inorganic materials 0.000 description 4
- 229910003827 NRaRb Inorganic materials 0.000 description 4
- 102000001253 Protein Kinase Human genes 0.000 description 4
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 4
- SIMJJYIGUQFXCG-UHFFFAOYSA-N [4-fluoro-1-tri(propan-2-yl)silylpyrrolo[2,3-b]pyridin-5-yl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC1=CN=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1F SIMJJYIGUQFXCG-UHFFFAOYSA-N 0.000 description 4
- WJEIYVAPNMUNIU-UHFFFAOYSA-N [Na].OC(O)=O Chemical compound [Na].OC(O)=O WJEIYVAPNMUNIU-UHFFFAOYSA-N 0.000 description 4
- PWVDWURTOBCLJW-UHFFFAOYSA-N benzyl 3-azido-4-hydroxypiperidine-1-carboxylate Chemical compound C1C(N=[N+]=[N-])C(O)CCN1C(=O)OCC1=CC=CC=C1 PWVDWURTOBCLJW-UHFFFAOYSA-N 0.000 description 4
- 229910000024 caesium carbonate Inorganic materials 0.000 description 4
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 4
- MPVDXIMFBOLMNW-UHFFFAOYSA-N chembl1615565 Chemical compound OC1=CC=C2C=C(S(O)(=O)=O)C=C(S(O)(=O)=O)C2=C1N=NC1=CC=CC=C1 MPVDXIMFBOLMNW-UHFFFAOYSA-N 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- VELDYOPRLMJFIK-UHFFFAOYSA-N cyclopentanecarbaldehyde Chemical compound O=CC1CCCC1 VELDYOPRLMJFIK-UHFFFAOYSA-N 0.000 description 4
- 231100000433 cytotoxic Toxicity 0.000 description 4
- 229940127089 cytotoxic agent Drugs 0.000 description 4
- 230000001472 cytotoxic effect Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 235000019441 ethanol Nutrition 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 125000005842 heteroatom Chemical group 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- DUAGZNPOPXJGOT-UHFFFAOYSA-N n-(5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl)-1-(1h-pyrrol-2-ylmethyl)pyrazole-4-carboxamide Chemical compound C12=CC(Br)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CN1 DUAGZNPOPXJGOT-UHFFFAOYSA-N 0.000 description 4
- XBPPJNNXAGYWRI-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methoxy-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-4-ylmethyl)pyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(OC)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=NC=C1 XBPPJNNXAGYWRI-QGZVFWFLSA-N 0.000 description 4
- HBFUKTPVCNGAFU-GOSISDBHSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methoxy-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(4-fluorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(OC)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=C(F)C=C1 HBFUKTPVCNGAFU-GOSISDBHSA-N 0.000 description 4
- PJOWZRBEUFUWFG-HSZRJFAPSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-phenyl-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(C=2C=CC=CC=2)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 PJOWZRBEUFUWFG-HSZRJFAPSA-N 0.000 description 4
- IFNPVACASQSGQR-MRXNPFEDSA-N n-[4-[(3r)-3-aminopyrrolidin-1-yl]-5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1[C@H](N)CCN1C1=C(Cl)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 IFNPVACASQSGQR-MRXNPFEDSA-N 0.000 description 4
- 230000037361 pathway Effects 0.000 description 4
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
- 125000003386 piperidinyl group Chemical group 0.000 description 4
- 108060006633 protein kinase Proteins 0.000 description 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 description 4
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 239000006188 syrup Substances 0.000 description 4
- 235000020357 syrup Nutrition 0.000 description 4
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- 239000003039 volatile agent Substances 0.000 description 4
- 229910052727 yttrium Inorganic materials 0.000 description 4
- RYNNPVYRYQJPEO-HNNXBMFYSA-N (2s)-1-methyl-2-[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]methyl]pyrrolidine Chemical compound CN1CCC[C@H]1COC1=CC=CC(B2OC(C)(C)C(C)(C)O2)=C1 RYNNPVYRYQJPEO-HNNXBMFYSA-N 0.000 description 3
- QSEMMUYKUYKNBI-UHFFFAOYSA-N (4-bromopyrrolo[2,3-b]pyridin-1-yl)-tri(propan-2-yl)silane Chemical compound C1=CN=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1Br QSEMMUYKUYKNBI-UHFFFAOYSA-N 0.000 description 3
- RRAXPOIWTUEFDD-UHFFFAOYSA-N (4-fluoro-1h-pyrrolo[2,3-b]pyridin-5-yl) 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OC1=CN=C2NC=CC2=C1F RRAXPOIWTUEFDD-UHFFFAOYSA-N 0.000 description 3
- QEYOHUBBPSKXMV-UHFFFAOYSA-N (4-fluoro-5-methoxypyrrolo[2,3-b]pyridin-1-yl)-tri(propan-2-yl)silane Chemical compound COC1=CN=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1F QEYOHUBBPSKXMV-UHFFFAOYSA-N 0.000 description 3
- AIJAFOFKGPWSSO-UHFFFAOYSA-N (5-bromo-4-fluoropyrrolo[2,3-b]pyridin-1-yl)-tri(propan-2-yl)silane Chemical compound BrC1=CN=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1F AIJAFOFKGPWSSO-UHFFFAOYSA-N 0.000 description 3
- FDWUFDIEKNWJQX-UHFFFAOYSA-N 1-(benzenesulfonyl)-4-chloro-5-(trifluoromethyl)pyrrolo[2,3-b]pyridine Chemical compound C1=CC2=C(Cl)C(C(F)(F)F)=CN=C2N1S(=O)(=O)C1=CC=CC=C1 FDWUFDIEKNWJQX-UHFFFAOYSA-N 0.000 description 3
- HYBRAUPLUXQZEG-UHFFFAOYSA-N 1-[(4-methylphenyl)methyl]pyrazole-4-carboxylic acid Chemical group C1=CC(C)=CC=C1CN1N=CC(C(O)=O)=C1 HYBRAUPLUXQZEG-UHFFFAOYSA-N 0.000 description 3
- KMOFOKGTZRFKEM-UHFFFAOYSA-N 1-[2-(3-bromophenoxy)ethyl]pyrrolidine Chemical compound BrC1=CC=CC(OCCN2CCCC2)=C1 KMOFOKGTZRFKEM-UHFFFAOYSA-N 0.000 description 3
- XEEBVHGZQKYBCD-UHFFFAOYSA-N 1-benzyl-N-(4-fluoro-5-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound Cc1cnc2[nH]cc(NC(=O)c3cnn(Cc4ccccc4)c3)c2c1F XEEBVHGZQKYBCD-UHFFFAOYSA-N 0.000 description 3
- HLYSRDACCKXGKI-UHFFFAOYSA-N 1-benzyl-N-(5-chloro-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound Fc1c(Cl)cnc2[nH]cc(NC(=O)c3cnn(Cc4ccccc4)c3)c12 HLYSRDACCKXGKI-UHFFFAOYSA-N 0.000 description 3
- XFPUFBHANVVZFG-UHFFFAOYSA-N 1-benzyl-N-[5-[4-[3-(dimethylamino)propoxy]phenyl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound CN(CCCOC1=CC=C(C=C1)C=1C=C2C(=NC1)N(C=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)S(=O)(=O)C2=CC=C(C=C2)C)C XFPUFBHANVVZFG-UHFFFAOYSA-N 0.000 description 3
- SKBZOZUZPJPMOH-UHFFFAOYSA-N 1-benzyl-n-[5-[1-[2-(diethylamino)ethyl]pyrazol-4-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CCN(CC)CC)C=C1C1=CN=C(NC=C2NC(=O)C3=CN(CC=4C=CC=CC=4)N=C3)C2=C1 SKBZOZUZPJPMOH-UHFFFAOYSA-N 0.000 description 3
- LIJLRHBIIZMMKG-UHFFFAOYSA-N 1-benzyl-n-[5-[3-(1-methylpiperidin-3-yl)oxyphenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1N(C)CCCC1OC1=CC=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=C1 LIJLRHBIIZMMKG-UHFFFAOYSA-N 0.000 description 3
- MPFNQGRSVYQEGR-UHFFFAOYSA-N 1-benzyl-n-[5-[3-(3-morpholin-4-ylpropoxy)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CC=CC=1OCCCN1CCOCC1 MPFNQGRSVYQEGR-UHFFFAOYSA-N 0.000 description 3
- OOTMYPYUUUELHQ-UHFFFAOYSA-N 1-benzyl-n-[5-[3-(oxetan-3-yloxy)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CC=CC=1OC1COC1 OOTMYPYUUUELHQ-UHFFFAOYSA-N 0.000 description 3
- SJEDDYYAUFEAIO-UHFFFAOYSA-N 1-benzyl-n-[5-[3-[(3,3-difluoropiperidin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1C(F)(F)CCCN1CC1=CC=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=C1 SJEDDYYAUFEAIO-UHFFFAOYSA-N 0.000 description 3
- BJJLYPIQEQCYLS-UHFFFAOYSA-N 1-benzyl-n-[5-[4-(piperidin-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=C1)=CC=C1CN1CCCCC1 BJJLYPIQEQCYLS-UHFFFAOYSA-N 0.000 description 3
- ZWCOYOQJKYJBIG-UHFFFAOYSA-N 1-benzyl-n-[5-[4-[3-(dimethylamino)propoxy]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=CC(OCCCN(C)C)=CC=C1C1=CN=C(NC=C2NC(=O)C3=CN(CC=4C=CC=CC=4)N=C3)C2=C1 ZWCOYOQJKYJBIG-UHFFFAOYSA-N 0.000 description 3
- XDRUKDNFTVGUGB-UHFFFAOYSA-N 1-benzyl-n-[5-[4-[[2-methoxyethyl(methyl)amino]methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=CC(CN(C)CCOC)=CC=C1C1=CN=C(NC=C2NC(=O)C3=CN(CC=4C=CC=CC=4)N=C3)C2=C1 XDRUKDNFTVGUGB-UHFFFAOYSA-N 0.000 description 3
- VCNOSUOVNNJQAB-UHFFFAOYSA-N 1-benzyl-n-[5-[5-(pyrrolidin-1-ylmethyl)thiophen-2-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(S1)=CC=C1CN1CCCC1 VCNOSUOVNNJQAB-UHFFFAOYSA-N 0.000 description 3
- KISRVFPBFBJTPK-UHFFFAOYSA-N 1-benzyl-n-[5-[5-(pyrrolidin-1-ylmethyl)thiophen-3-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CSC=1CN1CCCC1 KISRVFPBFBJTPK-UHFFFAOYSA-N 0.000 description 3
- NHOBBIVFUQBEMI-UHFFFAOYSA-N 1-methylsulfonylpyrrole-2-carbaldehyde Chemical compound CS(=O)(=O)N1C=CC=C1C=O NHOBBIVFUQBEMI-UHFFFAOYSA-N 0.000 description 3
- KOHBEDRJXKOYHL-UHFFFAOYSA-N 2-methoxy-n-methylethanamine Chemical compound CNCCOC KOHBEDRJXKOYHL-UHFFFAOYSA-N 0.000 description 3
- QLCHXZVEEOWYHL-UHFFFAOYSA-N 3-chloro-n,n,2,2-tetramethylpropan-1-amine;hydrochloride Chemical compound Cl.CN(C)CC(C)(C)CCl QLCHXZVEEOWYHL-UHFFFAOYSA-N 0.000 description 3
- BEPFGDZUAZYOHN-UHFFFAOYSA-N 4-bromo-3-nitro-7-azaindole Chemical compound C1=CC(Br)=C2C([N+](=O)[O-])=CNC2=N1 BEPFGDZUAZYOHN-UHFFFAOYSA-N 0.000 description 3
- VPSJPRMYBKNGOI-UHFFFAOYSA-N 4-chloro-3-nitro-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C(C(F)(F)F)C(Cl)=C2C([N+](=O)[O-])=CNC2=N1 VPSJPRMYBKNGOI-UHFFFAOYSA-N 0.000 description 3
- ATLADCFKPSZUNL-UHFFFAOYSA-N 4-chloro-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridine Chemical compound FC(F)(F)C1=CN=C2NC=CC2=C1Cl ATLADCFKPSZUNL-UHFFFAOYSA-N 0.000 description 3
- HHPQMGPENICAAD-UHFFFAOYSA-N 4-chloro-5-iodo-1h-pyrrolo[2,3-b]pyridine Chemical compound ClC1=C(I)C=NC2=C1C=CN2 HHPQMGPENICAAD-UHFFFAOYSA-N 0.000 description 3
- HIODJZBVHNCROX-UHFFFAOYSA-N 4-fluoro-5-methoxy-1h-pyrrolo[2,3-b]pyridine Chemical compound COC1=CN=C2NC=CC2=C1F HIODJZBVHNCROX-UHFFFAOYSA-N 0.000 description 3
- MHQHNMJVQKUNEQ-UHFFFAOYSA-N 4-fluoro-5-methoxy-3-nitro-1h-pyrrolo[2,3-b]pyridine Chemical compound COC1=CN=C2NC=C([N+]([O-])=O)C2=C1F MHQHNMJVQKUNEQ-UHFFFAOYSA-N 0.000 description 3
- DOXBRKCMQZDRGY-UHFFFAOYSA-N 4-fluoro-5-methyl-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound CC1=CN=C2NC=C(N)C2=C1F DOXBRKCMQZDRGY-UHFFFAOYSA-N 0.000 description 3
- FBLZOAQGIMCKEK-UHFFFAOYSA-N 4-fluoro-5-methyl-1h-pyrrolo[2,3-b]pyridine Chemical compound CC1=CN=C2NC=CC2=C1F FBLZOAQGIMCKEK-UHFFFAOYSA-N 0.000 description 3
- YYMPANVNHSGRDP-UHFFFAOYSA-N 4-fluoro-5-methyl-3-nitro-1h-pyrrolo[2,3-b]pyridine Chemical compound CC1=CN=C2NC=C([N+]([O-])=O)C2=C1F YYMPANVNHSGRDP-UHFFFAOYSA-N 0.000 description 3
- AOTXEIQACILNKS-UHFFFAOYSA-N 5-chloro-4-fluoro-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C(Cl)C(F)=C2C(N)=CNC2=N1 AOTXEIQACILNKS-UHFFFAOYSA-N 0.000 description 3
- NXFUJGIWFYKQGK-UHFFFAOYSA-N 5-chloro-4-fluoro-1h-pyrrolo[2,3-b]pyridine Chemical compound FC1=C(Cl)C=NC2=C1C=CN2 NXFUJGIWFYKQGK-UHFFFAOYSA-N 0.000 description 3
- YPMLOIUVRSZLKG-UHFFFAOYSA-N 5-chloro-4-fluoro-3-nitro-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C(Cl)C(F)=C2C([N+](=O)[O-])=CNC2=N1 YPMLOIUVRSZLKG-UHFFFAOYSA-N 0.000 description 3
- GHHWPSOGKLMSCJ-UHFFFAOYSA-N 507462-26-2 Chemical compound C1=C(Br)C=C2C([N+](=O)[O-])=CNC2=N1 GHHWPSOGKLMSCJ-UHFFFAOYSA-N 0.000 description 3
- SCGIEJZHILIERP-LLVKDONJSA-N CC(C)(C)CN[C@@H]1CCCN(C1)c1c(Br)cnc2[nH]cc(N)c12 Chemical compound CC(C)(C)CN[C@@H]1CCCN(C1)c1c(Br)cnc2[nH]cc(N)c12 SCGIEJZHILIERP-LLVKDONJSA-N 0.000 description 3
- BCGFDXHWKWLNQL-UHFFFAOYSA-N CN1N=CC(=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound CN1N=CC(=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 BCGFDXHWKWLNQL-UHFFFAOYSA-N 0.000 description 3
- 229910014455 Ca-Cb Inorganic materials 0.000 description 3
- VLZMDADZTOITSH-UHFFFAOYSA-N Cc1ccc(cc1)S(=O)(=O)n1cc(NC(=O)c2cnn(Cc3ccccc3)c2)c2cc(cnc12)-c1cccc(OCCN2CCCC2)c1 Chemical compound Cc1ccc(cc1)S(=O)(=O)n1cc(NC(=O)c2cnn(Cc3ccccc3)c2)c2cc(cnc12)-c1cccc(OCCN2CCCC2)c1 VLZMDADZTOITSH-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- JHQKHJMEWNLYMX-UHFFFAOYSA-N N-(5-chloro-4-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-(pyridin-4-ylmethyl)pyrazole-4-carboxamide Chemical compound Fc1c(Cl)cnc2[nH]cc(NC(=O)c3cnn(Cc4ccncc4)c3)c12 JHQKHJMEWNLYMX-UHFFFAOYSA-N 0.000 description 3
- LCMOAKKJWRIJPH-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1cccc(CN2CCC2)c1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1cccc(CN2CCC2)c1 LCMOAKKJWRIJPH-UHFFFAOYSA-N 0.000 description 3
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- OPJPCDCKLCWJON-HSZRJFAPSA-N [3-[(1-benzylpyrazole-4-carbonyl)amino]-4-[(3r)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-5-yl] 2,2-dimethylpropanoate Chemical compound C1[C@H](NC(=O)OC(C)(C)C)CCCN1C1=C(OC(=O)C(C)(C)C)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 OPJPCDCKLCWJON-HSZRJFAPSA-N 0.000 description 3
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 3
- VZTDIZULWFCMLS-UHFFFAOYSA-N ammonium formate Chemical compound [NH4+].[O-]C=O VZTDIZULWFCMLS-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- JPEMPGCPBAKNKS-MOPGFXCFSA-N benzyl (3r,4r)-4-cyclopropyl-3-(diethoxyphosphorylamino)piperidine-1-carboxylate Chemical compound C1([C@H]2CCN(C[C@@H]2NP(=O)(OCC)OCC)C(=O)OCC=2C=CC=CC=2)CC1 JPEMPGCPBAKNKS-MOPGFXCFSA-N 0.000 description 3
- LXLUFXYWZIVHSF-UHFFFAOYSA-N benzyl 3-(diethoxyphosphorylamino)-4-(4-methylphenyl)sulfonyloxypiperidine-1-carboxylate Chemical compound CCOP(=O)(OCC)NC1CN(C(=O)OCC=2C=CC=CC=2)CCC1OS(=O)(=O)C1=CC=C(C)C=C1 LXLUFXYWZIVHSF-UHFFFAOYSA-N 0.000 description 3
- AHVUFKFGWHXUDC-UHFFFAOYSA-N benzyl 4-azido-3-(4-methylphenyl)sulfonyloxypiperidine-1-carboxylate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC1C(N=[N+]=[N-])CCN(C(=O)OCC=2C=CC=CC=2)C1 AHVUFKFGWHXUDC-UHFFFAOYSA-N 0.000 description 3
- XOCCDWVWMPSHJU-UHFFFAOYSA-N benzyl 4-azido-3-hydroxypiperidine-1-carboxylate Chemical compound C1CC(N=[N+]=[N-])C(O)CN1C(=O)OCC1=CC=CC=C1 XOCCDWVWMPSHJU-UHFFFAOYSA-N 0.000 description 3
- BOZPVLJVKMWARN-UHFFFAOYSA-N benzyl 7-diethoxyphosphoryl-4,7-diazabicyclo[4.1.0]heptane-4-carboxylate Chemical compound C1C2N(P(=O)(OCC)OCC)C2CCN1C(=O)OCC1=CC=CC=C1 BOZPVLJVKMWARN-UHFFFAOYSA-N 0.000 description 3
- PHSSLYCBJRMEEV-UHFFFAOYSA-N benzyl 7-oxa-4-azabicyclo[4.1.0]heptane-4-carboxylate Chemical compound C1CC2OC2CN1C(=O)OCC1=CC=CC=C1 PHSSLYCBJRMEEV-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000022131 cell cycle Effects 0.000 description 3
- 229940044683 chemotherapy drug Drugs 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- OPTPGWNYYFAYHY-UHFFFAOYSA-N ethyl 1-[(1-methylsulfonylpyrrol-2-yl)methyl]pyrazole-4-carboxylate Chemical compound C1=C(C(=O)OCC)C=NN1CC1=CC=CN1S(C)(=O)=O OPTPGWNYYFAYHY-UHFFFAOYSA-N 0.000 description 3
- KACZQOKEFKFNDB-UHFFFAOYSA-N ethyl 1h-pyrazole-4-carboxylate Chemical compound CCOC(=O)C=1C=NNC=1 KACZQOKEFKFNDB-UHFFFAOYSA-N 0.000 description 3
- FDLDWKIEWAWOSL-UHFFFAOYSA-N ethyl acetate;2-methylpentane Chemical compound CCCC(C)C.CCOC(C)=O FDLDWKIEWAWOSL-UHFFFAOYSA-N 0.000 description 3
- 150000004675 formic acid derivatives Chemical class 0.000 description 3
- UWKQSNNFCGGAFS-XIFFEERXSA-N irinotecan Chemical compound C1=C2C(CC)=C3CN(C(C4=C([C@@](C(=O)OC4)(O)CC)C=4)=O)C=4C3=NC2=CC=C1OC(=O)N(CC1)CCC1N1CCCCC1 UWKQSNNFCGGAFS-XIFFEERXSA-N 0.000 description 3
- 229960004768 irinotecan Drugs 0.000 description 3
- 125000000842 isoxazolyl group Chemical group 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- SHUUEBOBDREAPE-UHFFFAOYSA-N n-(5-bromo-4-fluoro-1h-pyrrolo[2,3-b]pyridin-3-yl)-1-[(4-methoxyphenyl)methyl]pyrazole-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1N=CC(C(=O)NC=2C3=C(F)C(Br)=CN=C3NC=2)=C1 SHUUEBOBDREAPE-UHFFFAOYSA-N 0.000 description 3
- CFLVRAZWHBQIGQ-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(C(F)(F)F)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 CFLVRAZWHBQIGQ-QGZVFWFLSA-N 0.000 description 3
- XCPWMFLYGXCEGF-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-hydroxy-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(O)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 XCPWMFLYGXCEGF-QGZVFWFLSA-N 0.000 description 3
- NFVCVYOJNDBBOX-CTNGQTDRSA-N n-[4-[(3r,4r)-3-amino-4-cyclopropylpiperidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1([C@H]2CCN(C[C@@H]2N)C=2C=3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC=3N=CC=2Br)CC1 NFVCVYOJNDBBOX-CTNGQTDRSA-N 0.000 description 3
- 150000002825 nitriles Chemical class 0.000 description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 3
- 125000004043 oxo group Chemical group O=* 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 125000004076 pyridyl group Chemical group 0.000 description 3
- 125000000168 pyrrolyl group Chemical group 0.000 description 3
- 238000001959 radiotherapy Methods 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 239000012453 solvate Substances 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- GWIXKKVUKDHQOY-LLVKDONJSA-N tert-butyl n-[(3r)-1-(5-methoxy-3-nitro-1h-pyrrolo[2,3-b]pyridin-4-yl)piperidin-3-yl]carbamate Chemical compound COC1=CN=C2NC=C([N+]([O-])=O)C2=C1N1CCC[C@@H](NC(=O)OC(C)(C)C)C1 GWIXKKVUKDHQOY-LLVKDONJSA-N 0.000 description 3
- LRZZXMQRQHIQAQ-SNVBAGLBSA-N tert-butyl n-[(3r)-1-[3-amino-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl]carbamate Chemical compound C1[C@H](NC(=O)OC(C)(C)C)CCCN1C1=C(C(F)(F)F)C=NC2=C1C(N)=CN2 LRZZXMQRQHIQAQ-SNVBAGLBSA-N 0.000 description 3
- OGPCSYUFPBVGKD-SNVBAGLBSA-N tert-butyl n-[(3r)-1-[3-nitro-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl]carbamate Chemical compound C1[C@H](NC(=O)OC(C)(C)C)CCCN1C1=C(C(F)(F)F)C=NC2=C1C([N+]([O-])=O)=CN2 OGPCSYUFPBVGKD-SNVBAGLBSA-N 0.000 description 3
- GZNAASVAJNXPPW-UHFFFAOYSA-M tin(4+) chloride dihydrate Chemical compound O.O.[Cl-].[Sn+4] GZNAASVAJNXPPW-UHFFFAOYSA-M 0.000 description 3
- FWPIDFUJEMBDLS-UHFFFAOYSA-L tin(II) chloride dihydrate Substances O.O.Cl[Sn]Cl FWPIDFUJEMBDLS-UHFFFAOYSA-L 0.000 description 3
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 description 3
- HSMLARVFJADZQS-UHFFFAOYSA-N (4-chloropyrrolo[2,3-b]pyridin-1-yl)-tri(propan-2-yl)silane Chemical compound C1=CN=C2N([Si](C(C)C)(C(C)C)C(C)C)C=CC2=C1Cl HSMLARVFJADZQS-UHFFFAOYSA-N 0.000 description 2
- COIQUVGFTILYGA-UHFFFAOYSA-N (4-hydroxyphenyl)boronic acid Chemical compound OB(O)C1=CC=C(O)C=C1 COIQUVGFTILYGA-UHFFFAOYSA-N 0.000 description 2
- FDKXTQMXEQVLRF-ZHACJKMWSA-N (E)-dacarbazine Chemical compound CN(C)\N=N\c1[nH]cnc1C(N)=O FDKXTQMXEQVLRF-ZHACJKMWSA-N 0.000 description 2
- FSNGFFWICFYWQC-UHFFFAOYSA-N 1-(2-chloroethyl)pyrrolidine;hydron;chloride Chemical compound Cl.ClCCN1CCCC1 FSNGFFWICFYWQC-UHFFFAOYSA-N 0.000 description 2
- VXWPLQTVHINTNQ-UHFFFAOYSA-N 1-(benzenesulfonyl)-4-chloro-5-iodopyrrolo[2,3-b]pyridine Chemical compound C1=CC=2C(Cl)=C(I)C=NC=2N1S(=O)(=O)C1=CC=CC=C1 VXWPLQTVHINTNQ-UHFFFAOYSA-N 0.000 description 2
- CUDHNDFUGXHTRN-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1CC1=CC=CC=C1Cl CUDHNDFUGXHTRN-UHFFFAOYSA-N 0.000 description 2
- JMWJJDKQQMMJRG-UHFFFAOYSA-N 1-[(4-methoxyphenyl)methyl]pyrazole-4-carboxylic acid Chemical group C1=CC(OC)=CC=C1CN1N=CC(C(O)=O)=C1 JMWJJDKQQMMJRG-UHFFFAOYSA-N 0.000 description 2
- OUHKYWQKHLTDBH-UHFFFAOYSA-N 1-[fluoro(phenyl)methyl]pyrazole-4-carboxylic acid Chemical compound C1=C(C(=O)O)C=NN1C(F)C1=CC=CC=C1 OUHKYWQKHLTDBH-UHFFFAOYSA-N 0.000 description 2
- VGAFMEAQTYKXFH-UHFFFAOYSA-N 1-benzyl-N-[5-[1-[2-(diethylamino)ethyl]pyrazol-4-yl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C(C)N(CCN1N=CC(=C1)C=1C=C2C(=NC1)N(C=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)S(=O)(=O)C2=CC=C(C=C2)C)CC VGAFMEAQTYKXFH-UHFFFAOYSA-N 0.000 description 2
- HPJSOTCSLFGBGU-UHFFFAOYSA-N 1-benzyl-N-[5-[3-[(dimethylamino)methyl]phenyl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound CN(C)CC=1C=C(C=CC1)C=1C=C2C(=NC1)N(C=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)S(=O)(=O)C2=CC=C(C=C2)C HPJSOTCSLFGBGU-UHFFFAOYSA-N 0.000 description 2
- WMEWWDFWHBMCBM-UHFFFAOYSA-N 1-benzyl-n-(1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C=1NC2=NC=CC=C2C=1NC(=O)C(=C1)C=NN1CC1=CC=CC=C1 WMEWWDFWHBMCBM-UHFFFAOYSA-N 0.000 description 2
- QPLMQVLSVQFQTH-UHFFFAOYSA-N 1-benzyl-n-(5-piperidin-1-yl-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2N1CCCCC1 QPLMQVLSVQFQTH-UHFFFAOYSA-N 0.000 description 2
- XVAVLCVWQVUKSR-UHFFFAOYSA-N 1-benzyl-n-(5-pyridin-3-yl-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C1=CC=CN=C1 XVAVLCVWQVUKSR-UHFFFAOYSA-N 0.000 description 2
- YGPFFZKSUPWOQT-UHFFFAOYSA-N 1-benzyl-n-(5-pyridin-4-yl-1h-pyrrolo[2,3-b]pyridin-3-yl)pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C1=CC=NC=C1 YGPFFZKSUPWOQT-UHFFFAOYSA-N 0.000 description 2
- LYXOBSZCHAQLCV-UHFFFAOYSA-N 1-benzyl-n-[5-[5-[(3,3-difluoroazetidin-1-yl)methyl]thiophen-3-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1C(F)(F)CN1CC1=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=CS1 LYXOBSZCHAQLCV-UHFFFAOYSA-N 0.000 description 2
- BNGITRCRSAWPSZ-UHFFFAOYSA-N 1h-pyrrolo[2,3-b]pyridine Chemical compound C1=CN=C2N[C]=CC2=C1 BNGITRCRSAWPSZ-UHFFFAOYSA-N 0.000 description 2
- UWLHXRTWYGHNEM-UHFFFAOYSA-N 2-(chloromethyl)-1-methylsulfonylpyrrole Chemical compound CS(=O)(=O)N1C=CC=C1CCl UWLHXRTWYGHNEM-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- CDBAEFXTCRKJPZ-UHFFFAOYSA-N 3,3-difluoroazetidine;hydron;chloride Chemical group Cl.FC1(F)CNC1 CDBAEFXTCRKJPZ-UHFFFAOYSA-N 0.000 description 2
- MUKIFYQKIZOYKT-UHFFFAOYSA-N 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol Chemical compound O1C(C)(C)C(C)(C)OB1C1=CC=CC(O)=C1 MUKIFYQKIZOYKT-UHFFFAOYSA-N 0.000 description 2
- RDJUBLSLAULIAT-UHFFFAOYSA-N 3-fluoropiperidine;hydrochloride Chemical group Cl.FC1CCCNC1 RDJUBLSLAULIAT-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- LEZHTYOQWQEBLH-UHFFFAOYSA-N 4-bromo-1h-pyrrolo[2,3-b]pyridine Chemical compound BrC1=CC=NC2=C1C=CN2 LEZHTYOQWQEBLH-UHFFFAOYSA-N 0.000 description 2
- UMRGFHCHWMHAET-UHFFFAOYSA-N 4-fluoro-5-methoxy-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound COC1=CN=C2NC=C(N)C2=C1F UMRGFHCHWMHAET-UHFFFAOYSA-N 0.000 description 2
- SAVKOAJJSOGDHL-UHFFFAOYSA-N 5-[4-[3-(dimethylamino)propoxy]phenyl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=CC(OCCCN(C)C)=CC=C1C1=CN=C(NC=C2N)C2=C1 SAVKOAJJSOGDHL-UHFFFAOYSA-N 0.000 description 2
- TXNYLFGVDKRUOT-LLVKDONJSA-N 5-bromo-4-[(3R)-3-(cyclopropylmethylamino)piperidin-1-yl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound N([C@@H]1CCCN(C1)C=1C(Br)=CN=C2NC=C(C=12)N)CC1CC1 TXNYLFGVDKRUOT-LLVKDONJSA-N 0.000 description 2
- VZHJRYVFKSFRKL-UHFFFAOYSA-N 5-bromo-4-fluoro-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C(Br)C(F)=C2C(N)=CNC2=N1 VZHJRYVFKSFRKL-UHFFFAOYSA-N 0.000 description 2
- UVDDIZSAAWVACA-UHFFFAOYSA-N 5-methyl-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical group CC1=CN=C2NC=C(N)C2=C1 UVDDIZSAAWVACA-UHFFFAOYSA-N 0.000 description 2
- 125000004938 5-pyridyl group Chemical group N1=CC=CC(=C1)* 0.000 description 2
- TXRPBOFZDDOMNM-UHFFFAOYSA-N BrC=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC(=CC=C2)OC.N2=CC(=CC=C2)C=2C=C1C(=NC2)NC=C1NC(=O)C=1C=NN(C1)CC1=CC=CC=C1 Chemical compound BrC=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC(=CC=C2)OC.N2=CC(=CC=C2)C=2C=C1C(=NC2)NC=C1NC(=O)C=1C=NN(C1)CC1=CC=CC=C1 TXRPBOFZDDOMNM-UHFFFAOYSA-N 0.000 description 2
- 101100220616 Caenorhabditis elegans chk-2 gene Proteins 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- YLXXAERIKGIGMP-SECBINFHSA-N Cc1cnc2[nH]cc(N)c2c1N1CCC[C@@H](N)C1 Chemical compound Cc1cnc2[nH]cc(N)c2c1N1CCC[C@@H](N)C1 YLXXAERIKGIGMP-SECBINFHSA-N 0.000 description 2
- 230000033616 DNA repair Effects 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 2
- 240000007472 Leucaena leucocephala Species 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- HBIQGRBURSCEDY-OGFXRTJISA-N N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl.OC(C1=CN(CC2=CC=NC=C2)N=C1)=O Chemical compound N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl.OC(C1=CN(CC2=CC=NC=C2)N=C1)=O HBIQGRBURSCEDY-OGFXRTJISA-N 0.000 description 2
- HVQFBMREBFMHEW-ZCFIWIBFSA-N Nc1c[nH]c2ncc(Br)c(N3CC[C@@H](O)C3)c12 Chemical compound Nc1c[nH]c2ncc(Br)c(N3CC[C@@H](O)C3)c12 HVQFBMREBFMHEW-ZCFIWIBFSA-N 0.000 description 2
- 235000019502 Orange oil Nutrition 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- FXKSFAVNDYZPFN-CYBMUJFWSA-N [3-amino-4-[(3r)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-5-yl] 2,2-dimethylpropanoate Chemical compound C1[C@H](NC(=O)OC(C)(C)C)CCCN1C1=C(OC(=O)C(C)(C)C)C=NC2=C1C(N)=CN2 FXKSFAVNDYZPFN-CYBMUJFWSA-N 0.000 description 2
- 229960000583 acetic acid Drugs 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 150000001413 amino acids Chemical group 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- MVXVYAKCVDQRLW-UHFFFAOYSA-N azain Natural products C1=CN=C2NC=CC2=C1 MVXVYAKCVDQRLW-UHFFFAOYSA-N 0.000 description 2
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- YWKYQRWNOXUYJK-UHFFFAOYSA-N benzyl 3,6-dihydro-2h-pyridine-1-carboxylate Chemical compound C1CC=CCN1C(=O)OCC1=CC=CC=C1 YWKYQRWNOXUYJK-UHFFFAOYSA-N 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- IPWKHHSGDUIRAH-UHFFFAOYSA-N bis(pinacolato)diboron Chemical compound O1C(C)(C)C(C)(C)OB1B1OC(C)(C)C(C)(C)O1 IPWKHHSGDUIRAH-UHFFFAOYSA-N 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 125000002837 carbocyclic group Chemical group 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 230000012820 cell cycle checkpoint Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- KQIADDMXRMTWHZ-UHFFFAOYSA-N chloro-tri(propan-2-yl)silane Chemical compound CC(C)[Si](Cl)(C(C)C)C(C)C KQIADDMXRMTWHZ-UHFFFAOYSA-N 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- LGTLXDJOAJDFLR-UHFFFAOYSA-N diethyl chlorophosphate Chemical compound CCOP(Cl)(=O)OCC LGTLXDJOAJDFLR-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000001952 enzyme assay Methods 0.000 description 2
- DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 2
- 125000002541 furyl group Chemical group 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 150000004677 hydrates Chemical class 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 125000002883 imidazolyl group Chemical group 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000005865 ionizing radiation Effects 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 125000001786 isothiazolyl group Chemical group 0.000 description 2
- 231100000225 lethality Toxicity 0.000 description 2
- IOOMXAQUNPWDLL-UHFFFAOYSA-M lissamine rhodamine anion Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-M 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 231100000682 maximum tolerated dose Toxicity 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 101150071637 mre11 gene Proteins 0.000 description 2
- XRZNJPQJASFALN-UHFFFAOYSA-N n-(5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl)-1-[(2-cyanophenyl)methyl]pyrazole-4-carboxamide Chemical compound C12=CC(Br)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC=C1C#N XRZNJPQJASFALN-UHFFFAOYSA-N 0.000 description 2
- ASLYMEOTMCLKLQ-UHFFFAOYSA-N n-(5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl)-1-[(2-fluorophenyl)methyl]pyrazole-4-carboxamide Chemical compound FC1=CC=CC=C1CN1N=CC(C(=O)NC=2C3=CC(Br)=CN=C3NC=2)=C1 ASLYMEOTMCLKLQ-UHFFFAOYSA-N 0.000 description 2
- JHZHSQCMNHPMQR-UHFFFAOYSA-N n-(5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl)-1-[(4-fluorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C1=CC(F)=CC=C1CN1N=CC(C(=O)NC=2C3=CC(Br)=CN=C3NC=2)=C1 JHZHSQCMNHPMQR-UHFFFAOYSA-N 0.000 description 2
- YSEIJTJGIBDVBU-UHFFFAOYSA-N n-(5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl)-1-[(4-fluorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C1=CC(F)=CC=C1CN1N=CC(C(=O)NC=2C3=CC(Cl)=CN=C3NC=2)=C1 YSEIJTJGIBDVBU-UHFFFAOYSA-N 0.000 description 2
- RLKHFSNWQCZBDC-UHFFFAOYSA-N n-(benzenesulfonyl)-n-fluorobenzenesulfonamide Chemical compound C=1C=CC=CC=1S(=O)(=O)N(F)S(=O)(=O)C1=CC=CC=C1 RLKHFSNWQCZBDC-UHFFFAOYSA-N 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- AHTMQORKLQAAMI-MRXNPFEDSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-3-ylmethyl)pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=NC=CC=3)N=C1)=CN2 AHTMQORKLQAAMI-MRXNPFEDSA-N 0.000 description 2
- KWBOHFWRWKIONX-MRXNPFEDSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-4-ylmethyl)pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CN=CC=3)N=C1)=CN2 KWBOHFWRWKIONX-MRXNPFEDSA-N 0.000 description 2
- MZRXXLIYVNTBDV-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(4-methoxyphenyl)methyl]pyrazole-4-carboxamide Chemical compound C1=CC(OC)=CC=C1CN1N=CC(C(=O)NC=2C3=C(N4C[C@H](N)CCC4)C(Br)=CN=C3NC=2)=C1 MZRXXLIYVNTBDV-QGZVFWFLSA-N 0.000 description 2
- ZWZKABMEGYEOBX-MRXNPFEDSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-4-ylmethyl)pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(Cl)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CN=CC=3)N=C1)=CN2 ZWZKABMEGYEOBX-MRXNPFEDSA-N 0.000 description 2
- PHEWWHHWHGYFGW-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-fluoro-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(F)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 PHEWWHHWHGYFGW-QGZVFWFLSA-N 0.000 description 2
- LGOPTKMIOURNCV-LJQANCHMSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methoxy-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(2-methylphenyl)methyl]pyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(OC)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC=C1C LGOPTKMIOURNCV-LJQANCHMSA-N 0.000 description 2
- OYIXCSYMSNDXOH-GOSISDBHSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methoxy-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(3-fluorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(OC)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC(F)=C1 OYIXCSYMSNDXOH-GOSISDBHSA-N 0.000 description 2
- MPWNBGYRKVPEDL-LJQANCHMSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methoxy-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(3-methylphenyl)methyl]pyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(OC)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CC(C)=C1 MPWNBGYRKVPEDL-LJQANCHMSA-N 0.000 description 2
- BWALUAWCEKXXCM-GOSISDBHSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-3-ylmethyl)pyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(C)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=CN=C1 BWALUAWCEKXXCM-GOSISDBHSA-N 0.000 description 2
- ASUJIXSPTFXYHQ-GOSISDBHSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-methyl-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-4-ylmethyl)pyrazole-4-carboxamide Chemical compound C12=C(N3C[C@H](N)CCC3)C(C)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=NC=C1 ASUJIXSPTFXYHQ-GOSISDBHSA-N 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000010502 orange oil Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 125000002971 oxazolyl group Chemical group 0.000 description 2
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 125000003226 pyrazolyl group Chemical group 0.000 description 2
- QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229960001866 silicon dioxide Drugs 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- DYHSDKLCOJIUFX-UHFFFAOYSA-N tert-butoxycarbonyl anhydride Chemical compound CC(C)(C)OC(=O)OC(=O)OC(C)(C)C DYHSDKLCOJIUFX-UHFFFAOYSA-N 0.000 description 2
- PXPBIKLQGJBGRG-HXUWFJFHSA-N tert-butyl n-[(3r)-1-[3-[[1-[(4-fluorophenyl)methyl]pyrazole-4-carbonyl]amino]-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl]carbamate Chemical compound C1[C@H](NC(=O)OC(C)(C)C)CCCN1C1=C(C(F)(F)F)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC(F)=CC=3)N=C1)=CN2 PXPBIKLQGJBGRG-HXUWFJFHSA-N 0.000 description 2
- MBSRUUCAYDFSGF-OAQYLSRUSA-N tert-butyl n-[(3r)-1-[3-[[1-[(4-fluorophenyl)methyl]pyrazole-4-carbonyl]amino]-5-methoxy-1h-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl]carbamate Chemical compound C12=C(N3C[C@@H](CCC3)NC(=O)OC(C)(C)C)C(OC)=CN=C2NC=C1NC(=O)C(=C1)C=NN1CC1=CC=C(F)C=C1 MBSRUUCAYDFSGF-OAQYLSRUSA-N 0.000 description 2
- DQQJBEAXSOOCPG-SSDOTTSWSA-N tert-butyl n-[(3r)-pyrrolidin-3-yl]carbamate Chemical group CC(C)(C)OC(=O)N[C@@H]1CCNC1 DQQJBEAXSOOCPG-SSDOTTSWSA-N 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 125000001113 thiadiazolyl group Chemical group 0.000 description 2
- 125000000335 thiazolyl group Chemical group 0.000 description 2
- 125000001544 thienyl group Chemical group 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- GTLDTDOJJJZVBW-UHFFFAOYSA-N zinc cyanide Chemical compound [Zn+2].N#[C-].N#[C-] GTLDTDOJJJZVBW-UHFFFAOYSA-N 0.000 description 2
- VLECDMDGMKPUSK-NUBCRITNSA-N (3r)-piperidin-3-ol;hydrochloride Chemical group Cl.O[C@@H]1CCCNC1 VLECDMDGMKPUSK-NUBCRITNSA-N 0.000 description 1
- JHHZLHWJQPUNKB-SCSAIBSYSA-N (3r)-pyrrolidin-3-ol Chemical group O[C@@H]1CCNC1 JHHZLHWJQPUNKB-SCSAIBSYSA-N 0.000 description 1
- VXWBQOJISHAKKM-UHFFFAOYSA-N (4-formylphenyl)boronic acid Chemical compound OB(O)C1=CC=C(C=O)C=C1 VXWBQOJISHAKKM-UHFFFAOYSA-N 0.000 description 1
- DEQOVKFWRPOPQP-UHFFFAOYSA-N (5-formylthiophen-2-yl)boronic acid Chemical group OB(O)C1=CC=C(C=O)S1 DEQOVKFWRPOPQP-UHFFFAOYSA-N 0.000 description 1
- ZCUFJAORCNFWOF-UHFFFAOYSA-N (5-formylthiophen-3-yl)boronic acid Chemical group OB(O)C1=CSC(C=O)=C1 ZCUFJAORCNFWOF-UHFFFAOYSA-N 0.000 description 1
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 description 1
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- NVNPLEPBDPJYRZ-UHFFFAOYSA-N 1-(bromomethyl)-4-fluorobenzene Chemical compound FC1=CC=C(CBr)C=C1 NVNPLEPBDPJYRZ-UHFFFAOYSA-N 0.000 description 1
- ALSCRMRUUIZZBO-UHFFFAOYSA-N 1-[(2-cyanophenyl)methyl]pyrazole-4-carboxylic acid Chemical group C1=C(C(=O)O)C=NN1CC1=CC=CC=C1C#N ALSCRMRUUIZZBO-UHFFFAOYSA-N 0.000 description 1
- SEVWRBACKOQREE-UHFFFAOYSA-N 1-[(2-fluorophenyl)methyl]pyrazole-4-carboxylic acid Chemical group C1=C(C(=O)O)C=NN1CC1=CC=CC=C1F SEVWRBACKOQREE-UHFFFAOYSA-N 0.000 description 1
- QELIFVMICKIPRJ-UHFFFAOYSA-N 1-[(2-methylphenyl)methyl]pyrazole-4-carboxylic acid Chemical group CC1=CC=CC=C1CN1N=CC(C(O)=O)=C1 QELIFVMICKIPRJ-UHFFFAOYSA-N 0.000 description 1
- IVDPFMFNQXHGNX-UHFFFAOYSA-N 1-[(3-fluorophenyl)methyl]pyrazole-4-carboxylic acid Chemical group C1=C(C(=O)O)C=NN1CC1=CC=CC(F)=C1 IVDPFMFNQXHGNX-UHFFFAOYSA-N 0.000 description 1
- PBGWCCZEAHKYKB-UHFFFAOYSA-N 1-[(3-methylphenyl)methyl]pyrazole-4-carboxylic acid Chemical group CC1=CC=CC(CN2N=CC(=C2)C(O)=O)=C1 PBGWCCZEAHKYKB-UHFFFAOYSA-N 0.000 description 1
- ATWXYVDFJLESJV-UHFFFAOYSA-N 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyrrolidine Chemical group O1C(C)(C)C(C)(C)OB1C1=CC=CC(N2CCCC2)=C1 ATWXYVDFJLESJV-UHFFFAOYSA-N 0.000 description 1
- SYYBDNPGDKKJDU-ZDUSSCGKSA-N 1-[5-bromo-4-methyl-2-[[(2S)-2-morpholinyl]methoxy]phenyl]-3-(5-methyl-2-pyrazinyl)urea Chemical compound C1=NC(C)=CN=C1NC(=O)NC1=CC(Br)=C(C)C=C1OC[C@H]1OCCNC1 SYYBDNPGDKKJDU-ZDUSSCGKSA-N 0.000 description 1
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 1
- FNUNODOPANYPJX-UHFFFAOYSA-N 1-benzyl-N-[1-(4-methylphenyl)sulfonyl-5-[3-(1-methylpiperidin-3-yl)oxyphenyl]pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound CN1CC(CCC1)OC=1C=C(C=CC1)C=1C=C2C(=NC1)N(C=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)S(=O)(=O)C2=CC=C(C=C2)C FNUNODOPANYPJX-UHFFFAOYSA-N 0.000 description 1
- IIWWOSRETZGKGC-HKBQPEDESA-N 1-benzyl-N-[1-(4-methylphenyl)sulfonyl-5-[3-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]phenyl]pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound CN1CCC[C@H]1COc1cccc(c1)-c1cnc2n(cc(NC(=O)c3cnn(Cc4ccccc4)c3)c2c1)S(=O)(=O)c1ccc(C)cc1 IIWWOSRETZGKGC-HKBQPEDESA-N 0.000 description 1
- ZXPMQTKJDAVJIN-UHFFFAOYSA-N 1-benzyl-N-[5-(5-formylthiophen-2-yl)-1H-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C(=O)C1=CC=C(S1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 ZXPMQTKJDAVJIN-UHFFFAOYSA-N 0.000 description 1
- DLSLDFAQJNGMKK-UHFFFAOYSA-N 1-benzyl-N-[5-[3-[(3,3-difluoropiperidin-1-yl)methyl]phenyl]-1-(4-methylphenyl)sulfonylpyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound FC1(CN(CCC1)CC=1C=C(C=CC=1)C=1C=C2C(=NC=1)N(C=C2NC(=O)C=1C=NN(C=1)CC1=CC=CC=C1)S(=O)(=O)C1=CC=C(C=C1)C)F DLSLDFAQJNGMKK-UHFFFAOYSA-N 0.000 description 1
- VRHKTPMCIVSRJQ-UHFFFAOYSA-N 1-benzyl-n-[5-(3-pyrrolidin-1-ylphenyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CC=CC=1N1CCCC1 VRHKTPMCIVSRJQ-UHFFFAOYSA-N 0.000 description 1
- KPNGWKHUIVRLGR-UHFFFAOYSA-N 1-benzyl-n-[5-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(=C1)C=NN1CCN1CCCC1 KPNGWKHUIVRLGR-UHFFFAOYSA-N 0.000 description 1
- HLZMBGHAGVCGKD-UHFFFAOYSA-N 1-benzyl-n-[5-[2-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C=1C=C(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)C(F)=CC=1CN1CCCC1 HLZMBGHAGVCGKD-UHFFFAOYSA-N 0.000 description 1
- FKVNJWFPVGBMHU-UHFFFAOYSA-N 1-benzyl-n-[5-[3-(pyrrolidin-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CC=CC=1CN1CCCC1 FKVNJWFPVGBMHU-UHFFFAOYSA-N 0.000 description 1
- SXYOIQPOSWUZHF-UHFFFAOYSA-N 1-benzyl-n-[5-[3-[(3,3-difluoroazetidin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1C(F)(F)CN1CC1=CC=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=C1 SXYOIQPOSWUZHF-UHFFFAOYSA-N 0.000 description 1
- SFIBYAJMZBUDEP-UHFFFAOYSA-N 1-benzyl-n-[5-[3-[(3-fluoropiperidin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1C(F)CCCN1CC1=CC=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=C1 SFIBYAJMZBUDEP-UHFFFAOYSA-N 0.000 description 1
- RCKUZUSNWYHRIU-UHFFFAOYSA-N 1-benzyl-n-[5-[3-[3-(dimethylamino)-2,2-dimethylpropoxy]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound CN(C)CC(C)(C)COC1=CC=CC(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)=C1 RCKUZUSNWYHRIU-UHFFFAOYSA-N 0.000 description 1
- COGQQFNLQDLLDI-UHFFFAOYSA-N 1-benzyl-n-[5-[4-(methylaminomethyl)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=CC(CNC)=CC=C1C1=CN=C(NC=C2NC(=O)C3=CN(CC=4C=CC=CC=4)N=C3)C2=C1 COGQQFNLQDLLDI-UHFFFAOYSA-N 0.000 description 1
- IQBWEJGHTHXWAW-UHFFFAOYSA-N 1-benzyl-n-[5-[4-(morpholin-4-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=C1)=CC=C1CN1CCOCC1 IQBWEJGHTHXWAW-UHFFFAOYSA-N 0.000 description 1
- ZMCSBUCSRQVLBA-UHFFFAOYSA-N 1-benzyl-n-[5-[4-(pyrrolidin-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=C1)=CC=C1CN1CCCC1 ZMCSBUCSRQVLBA-UHFFFAOYSA-N 0.000 description 1
- BLLXERLFSOJNOT-UHFFFAOYSA-N 1-benzyl-n-[5-[4-[(3,3-difluoropyrrolidin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1C(F)(F)CCN1CC1=CC=C(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)C=C1 BLLXERLFSOJNOT-UHFFFAOYSA-N 0.000 description 1
- WRVVBGFYPHYTGJ-UHFFFAOYSA-N 1-benzyl-n-[5-[4-[(3-fluoropiperidin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1C(F)CCCN1CC1=CC=C(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)C=C1 WRVVBGFYPHYTGJ-UHFFFAOYSA-N 0.000 description 1
- JENONEIRHGQXAF-UHFFFAOYSA-N 1-benzyl-n-[5-[4-[(4-fluoropiperidin-1-yl)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1CC(F)CCN1CC1=CC=C(C=2C=C3C(NC(=O)C4=CN(CC=5C=CC=CC=5)N=C4)=CNC3=NC=2)C=C1 JENONEIRHGQXAF-UHFFFAOYSA-N 0.000 description 1
- HUEAWOHEOVJAGH-UHFFFAOYSA-N 1-benzyl-n-[5-[4-[(dimethylamino)methyl]phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1=CC(CN(C)C)=CC=C1C1=CN=C(NC=C2NC(=O)C3=CN(CC=4C=CC=CC=4)N=C3)C2=C1 HUEAWOHEOVJAGH-UHFFFAOYSA-N 0.000 description 1
- VNMIEOYDXHEBID-OAQYLSRUSA-N 1-benzyl-n-[5-bromo-4-[(3r)-3-(2-methylpropylamino)piperidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1[C@H](NCC(C)C)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 VNMIEOYDXHEBID-OAQYLSRUSA-N 0.000 description 1
- QZQBBQDPZSEQAX-LJQANCHMSA-N 1-benzyl-n-[5-bromo-4-[(3r)-3-(ethylamino)piperidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1[C@H](NCC)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 QZQBBQDPZSEQAX-LJQANCHMSA-N 0.000 description 1
- YJMRDASTXLIUJT-GOSISDBHSA-N 1-benzyl-n-[5-bromo-4-[(3r)-3-(methylamino)piperidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1[C@H](NC)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 YJMRDASTXLIUJT-GOSISDBHSA-N 0.000 description 1
- XUNIQFSPDUAMQG-QGZVFWFLSA-N 1-benzyl-n-[5-bromo-4-[(3r)-3-hydroxypiperidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1[C@H](O)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 XUNIQFSPDUAMQG-QGZVFWFLSA-N 0.000 description 1
- UOOLXMHPWCOLLX-MRXNPFEDSA-N 1-benzyl-n-[5-bromo-4-[(3r)-3-hydroxypyrrolidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1[C@H](O)CCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 UOOLXMHPWCOLLX-MRXNPFEDSA-N 0.000 description 1
- MBURDEXNWSTAFU-UHFFFAOYSA-N 1-benzyl-n-[5-bromo-4-[3-(dimethylamino)piperidin-1-yl]-1h-pyrrolo[2,3-b]pyridin-3-yl]pyrazole-4-carboxamide Chemical compound C1C(N(C)C)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 MBURDEXNWSTAFU-UHFFFAOYSA-N 0.000 description 1
- RBYWKNNPGORGMC-UHFFFAOYSA-N 1-benzylpyrazole-4-carboxylic acid 5-[5-[(3,3-difluoroazetidin-1-yl)methyl]thiophen-3-yl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound NC(C1=C2)=CNC1=NC=C2C1=CSC(CN(C2)CC2(F)F)=C1.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O RBYWKNNPGORGMC-UHFFFAOYSA-N 0.000 description 1
- UCNGGGYMLHAMJG-UHFFFAOYSA-N 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazole Chemical group C1=NN(C)C=C1B1OC(C)(C)C(C)(C)O1 UCNGGGYMLHAMJG-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HCTKTFWOSSBSIL-UHFFFAOYSA-N 1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=CC=C2C(N)=CNC2=N1 HCTKTFWOSSBSIL-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- IEQAICDLOKRSRL-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO IEQAICDLOKRSRL-UHFFFAOYSA-N 0.000 description 1
- HLMHCDKXKXBKQK-UHFFFAOYSA-N 2-bromoethyl(diethyl)azanium;bromide Chemical compound Br.CCN(CC)CCBr HLMHCDKXKXBKQK-UHFFFAOYSA-N 0.000 description 1
- ILJKKAIQFPEIBL-UHFFFAOYSA-N 2-cyclopropyl-2-hydroxyacetonitrile Chemical group N#CC(O)C1CC1 ILJKKAIQFPEIBL-UHFFFAOYSA-N 0.000 description 1
- CTRPRMNBTVRDFH-UHFFFAOYSA-N 2-n-methyl-1,3,5-triazine-2,4,6-triamine Chemical compound CNC1=NC(N)=NC(N)=N1 CTRPRMNBTVRDFH-UHFFFAOYSA-N 0.000 description 1
- LEHHIPIDKQVNEV-UHFFFAOYSA-N 3,3-difluoropiperidine;hydrochloride Chemical group Cl.FC1(F)CCCNC1 LEHHIPIDKQVNEV-UHFFFAOYSA-N 0.000 description 1
- YYVPZQADFREIFR-UHFFFAOYSA-N 3,3-difluoropyrrolidine;hydrochloride Chemical group [Cl-].FC1(F)CC[NH2+]C1 YYVPZQADFREIFR-UHFFFAOYSA-N 0.000 description 1
- XEZLBMHDUXSICI-UHFFFAOYSA-N 3-(1-ethylpiperidin-4-yl)oxy-5,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaene-4-carbonitrile Chemical compound C1CN(CC)CCC1OC1=C(C#N)N=CC2=C1C1=CC=CN=C1N2 XEZLBMHDUXSICI-UHFFFAOYSA-N 0.000 description 1
- VZYZKPJAXWDZFT-UHFFFAOYSA-N 3-(bromomethyl)-1-methylpiperidine Chemical group CN1CCCC(CBr)C1 VZYZKPJAXWDZFT-UHFFFAOYSA-N 0.000 description 1
- IAYGCINLNONXHY-LBPRGKRZSA-N 3-(carbamoylamino)-5-(3-fluorophenyl)-N-[(3S)-3-piperidinyl]-2-thiophenecarboxamide Chemical compound NC(=O)NC=1C=C(C=2C=C(F)C=CC=2)SC=1C(=O)N[C@H]1CCCNC1 IAYGCINLNONXHY-LBPRGKRZSA-N 0.000 description 1
- PYEWZDAEJUUIJX-UHFFFAOYSA-N 3-(dimethylamino)-2,2-dimethylpropan-1-ol Chemical compound CN(C)CC(C)(C)CO PYEWZDAEJUUIJX-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- MNOJRWOWILAHAV-UHFFFAOYSA-N 3-bromophenol Chemical compound OC1=CC=CC(Br)=C1 MNOJRWOWILAHAV-UHFFFAOYSA-N 0.000 description 1
- LJQNMDZRCXJETK-UHFFFAOYSA-N 3-chloro-n,n-dimethylpropan-1-amine;hydron;chloride Chemical compound Cl.CN(C)CCCCl LJQNMDZRCXJETK-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- KBEIFKMKVCDETC-UHFFFAOYSA-N 3-iodooxetane Chemical group IC1COC1 KBEIFKMKVCDETC-UHFFFAOYSA-N 0.000 description 1
- FTAHXMZRJCZXDL-UHFFFAOYSA-N 3-piperideine Chemical compound C1CC=CCN1 FTAHXMZRJCZXDL-UHFFFAOYSA-N 0.000 description 1
- ZAPMTSHEXFEPSD-UHFFFAOYSA-N 4-(2-chloroethyl)morpholine Chemical compound ClCCN1CCOCC1 ZAPMTSHEXFEPSD-UHFFFAOYSA-N 0.000 description 1
- PIAZYBLGBSMNLX-UHFFFAOYSA-N 4-(3-chloropropyl)morpholine Chemical group ClCCCN1CCOCC1 PIAZYBLGBSMNLX-UHFFFAOYSA-N 0.000 description 1
- HXWHKHVVPMTTLJ-CYBMUJFWSA-N 4-[(3R)-3-aminopiperidin-1-yl]-5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1[C@H](N)CCCN1C1=C(C=2C=CC=CC=2)C=NC2=C1C(N)=CN2 HXWHKHVVPMTTLJ-CYBMUJFWSA-N 0.000 description 1
- SZDGCPAAQKHPFH-ZCFIWIBFSA-N 4-[(3R)-3-aminopyrrolidin-1-yl]-5-chloro-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1[C@H](N)CCN1C1=C(Cl)C=NC2=C1C(N)=CN2 SZDGCPAAQKHPFH-ZCFIWIBFSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- BZBNGPXWPOQJPT-UHFFFAOYSA-N 4-bromo-1,2-dihydropyrrolo[3,2-b]pyridine Chemical compound BrN1C=CC=C2NCC=C12 BZBNGPXWPOQJPT-UHFFFAOYSA-N 0.000 description 1
- WVGCPEDBFHEHEZ-UHFFFAOYSA-N 4-bromo-1h-pyrazole Chemical compound BrC=1C=NNC=1 WVGCPEDBFHEHEZ-UHFFFAOYSA-N 0.000 description 1
- HNTZVGMWXCFCTA-UHFFFAOYSA-N 4-chloro-1h-pyrrolo[2,3-b]pyridine Chemical group ClC1=CC=NC2=C1C=CN2 HNTZVGMWXCFCTA-UHFFFAOYSA-N 0.000 description 1
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
- IXENWFQXVCOHAZ-UHFFFAOYSA-N 4-fluoropiperidine;hydrochloride Chemical group Cl.FC1CCNCC1 IXENWFQXVCOHAZ-UHFFFAOYSA-N 0.000 description 1
- CAIZJLPXHFFJFO-UHFFFAOYSA-N 5-[1-(2-pyrrolidin-1-ylethyl)pyrazol-4-yl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C2C(N)=CNC2=NC=C1C(=C1)C=NN1CCN1CCCC1 CAIZJLPXHFFJFO-UHFFFAOYSA-N 0.000 description 1
- OEHQEMWNVNXSPE-UHFFFAOYSA-N 5-[3-(2-morpholin-4-ylethoxy)phenyl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C2C(N)=CNC2=NC=C1C(C=1)=CC=CC=1OCCN1CCOCC1 OEHQEMWNVNXSPE-UHFFFAOYSA-N 0.000 description 1
- JTIFJTIBYDWWJO-UHFFFAOYSA-N 5-[3-[(1-methylpiperidin-3-yl)methoxy]phenyl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1N(C)CCCC1COC1=CC=CC(C=2C=C3C(N)=CNC3=NC=2)=C1 JTIFJTIBYDWWJO-UHFFFAOYSA-N 0.000 description 1
- QZIVPSUZFSQBKH-UHFFFAOYSA-N 5-[3-[(3,3-difluoropiperidin-1-yl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C2C(N)=CNC2=NC=C1C(C=1)=CC=CC=1CN1CCCC(F)(F)C1 QZIVPSUZFSQBKH-UHFFFAOYSA-N 0.000 description 1
- XOEZQJWSGXVJAB-UHFFFAOYSA-N 5-[4-[(3-fluoropiperidin-1-yl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C2C(N)=CNC2=NC=C1C(C=C1)=CC=C1CN1CCCC(F)C1 XOEZQJWSGXVJAB-UHFFFAOYSA-N 0.000 description 1
- KHWHOZAZVCZUJJ-UHFFFAOYSA-N 5-[4-[(4-fluoropiperidin-1-yl)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C2C(N)=CNC2=NC=C1C(C=C1)=CC=C1CN1CCC(F)CC1 KHWHOZAZVCZUJJ-UHFFFAOYSA-N 0.000 description 1
- ANNXLXWBHJQDHZ-UHFFFAOYSA-N 5-[5-[(3,3-difluoroazetidin-1-yl)methyl]thiophen-3-yl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C2C(N)=CNC2=NC=C1C(C=1)=CSC=1CN1CC(F)(F)C1 ANNXLXWBHJQDHZ-UHFFFAOYSA-N 0.000 description 1
- YALUKZAGHLPXPO-CYBMUJFWSA-N 5-bromo-4-[(3R)-3-(cyclopentylmethylamino)piperidin-1-yl]-1H-pyrrolo[2,3-b]pyridin-3-amine Chemical compound N([C@@H]1CCCN(C1)C=1C(Br)=CN=C2NC=C(C=12)N)CC1CCCC1 YALUKZAGHLPXPO-CYBMUJFWSA-N 0.000 description 1
- MFZQJIKENSPRSJ-UHFFFAOYSA-N 5-chloro-1h-pyrrolo[2,3-b]pyridine Chemical group ClC1=CN=C2NC=CC2=C1 MFZQJIKENSPRSJ-UHFFFAOYSA-N 0.000 description 1
- DEZAIQUWOITSPT-UHFFFAOYSA-N 5-chloro-3-nitro-1h-pyrrolo[2,3-b]pyridine Chemical compound C1=C(Cl)C=C2C([N+](=O)[O-])=CNC2=N1 DEZAIQUWOITSPT-UHFFFAOYSA-N 0.000 description 1
- DJCJHFFRHKGOCQ-UHFFFAOYSA-N 5-methyl-1h-pyrrolo[2,3-b]pyridine Chemical group CC1=CN=C2NC=CC2=C1 DJCJHFFRHKGOCQ-UHFFFAOYSA-N 0.000 description 1
- OWGGSXQRLHNDGC-UHFFFAOYSA-N 5-methyl-3-nitro-1h-pyrrolo[2,3-b]pyridine Chemical group CC1=CN=C2NC=C([N+]([O-])=O)C2=C1 OWGGSXQRLHNDGC-UHFFFAOYSA-N 0.000 description 1
- FABOGBCGXOXMKJ-UHFFFAOYSA-N 5-phenyl-1h-pyrrolo[2,3-b]pyridin-3-amine Chemical compound C1=C2C(N)=CNC2=NC=C1C1=CC=CC=C1 FABOGBCGXOXMKJ-UHFFFAOYSA-N 0.000 description 1
- GMIZZEXBPRLVIV-SECBINFHSA-N 6-bromo-3-(1-methylpyrazol-4-yl)-5-[(3r)-piperidin-3-yl]pyrazolo[1,5-a]pyrimidin-7-amine Chemical compound C1=NN(C)C=C1C1=C2N=C([C@H]3CNCCC3)C(Br)=C(N)N2N=C1 GMIZZEXBPRLVIV-SECBINFHSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
- 239000012099 Alexa Fluor family Substances 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 108010024976 Asparaginase Proteins 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000937413 Axia Species 0.000 description 1
- NOWKCMXCCJGMRR-UHFFFAOYSA-N Aziridine Chemical compound C1CN1 NOWKCMXCCJGMRR-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- LLOQOEIEKWFHRV-UHFFFAOYSA-N BrC=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=C(C=CC=C2)C#N.BrC=2C=C1C(=NC2)NC=C1NC(=O)C=1C=NN(C1)CC1=C(C=CC=C1)F Chemical compound BrC=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=C(C=CC=C2)C#N.BrC=2C=C1C(=NC2)NC=C1NC(=O)C=1C=NN(C1)CC1=C(C=CC=C1)F LLOQOEIEKWFHRV-UHFFFAOYSA-N 0.000 description 1
- COVZYZSDYWQREU-UHFFFAOYSA-N Busulfan Chemical compound CS(=O)(=O)OCCCCOS(C)(=O)=O COVZYZSDYWQREU-UHFFFAOYSA-N 0.000 description 1
- OGMPGWHSCRAOJC-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.BrC=1C(=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)N2CC(CCC2)N(C)C Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.BrC=1C(=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)N2CC(CCC2)N(C)C OGMPGWHSCRAOJC-UHFFFAOYSA-N 0.000 description 1
- BMGLURLQYUOSQF-FSRHSHDFSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.BrC=1C(=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)N2C[C@@H](CCC2)NCC Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.BrC=1C(=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)N2C[C@@H](CCC2)NCC BMGLURLQYUOSQF-FSRHSHDFSA-N 0.000 description 1
- CLOWZCJCZNXHOG-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.C(C)N(CCN1N=CC(=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)CC Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.C(C)N(CCN1N=CC(=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)CC CLOWZCJCZNXHOG-UHFFFAOYSA-N 0.000 description 1
- PCTMORGVTOSOJE-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.CN(C)CC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.CN(C)CC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 PCTMORGVTOSOJE-UHFFFAOYSA-N 0.000 description 1
- XBMFSGXLIPBRKO-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.CN(CC(COC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)(C)C)C Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.CN(CC(COC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2)(C)C)C XBMFSGXLIPBRKO-UHFFFAOYSA-N 0.000 description 1
- PKVCTXDIQCVNNP-UQIIZPHYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.CN1[C@@H](CCC1)COC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.CN1[C@@H](CCC1)COC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 PKVCTXDIQCVNNP-UQIIZPHYSA-N 0.000 description 1
- IUEZQVCAQYRAFK-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.FC1CN(CCC1)CC1=CC=C(C=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.FC1CN(CCC1)CC1=CC=C(C=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 IUEZQVCAQYRAFK-UHFFFAOYSA-N 0.000 description 1
- XBOFWHNVUMQWFJ-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N1(CCCC1)CC1=CC=C(C=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N1(CCCC1)CC1=CC=C(C=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 XBOFWHNVUMQWFJ-UHFFFAOYSA-N 0.000 description 1
- QLEAMDSDDJDRHO-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N1(CCCC1)CC1=CC=C(S1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N1(CCCC1)CC1=CC=C(S1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 QLEAMDSDDJDRHO-UHFFFAOYSA-N 0.000 description 1
- UGGAJCLMYNPURU-PKLMIRHRSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N[C@H]1CN(CC1)C1=C2C(=NC=C1Br)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N[C@H]1CN(CC1)C1=C2C(=NC=C1Br)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 UGGAJCLMYNPURU-PKLMIRHRSA-N 0.000 description 1
- GXMZVJHJKMXIIA-GNAFDRTKSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N[C@H]1CN(CCC1)C1=C2C(=NC=C1C1=CC=CC=C1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.N[C@H]1CN(CCC1)C1=C2C(=NC=C1C1=CC=CC=C1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 GXMZVJHJKMXIIA-GNAFDRTKSA-N 0.000 description 1
- AMIUXBXGZNSUEB-UHFFFAOYSA-N C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.O1CC(C1)OC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 Chemical compound C(C1=CC=CC=C1)N1N=CC(=C1)C(=O)O.O1CC(C1)OC=1C=C(C=CC1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2 AMIUXBXGZNSUEB-UHFFFAOYSA-N 0.000 description 1
- HWNDZLSNNWFFEJ-SBSPUUFOSA-N CC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC(C=C2)=CC=C2F)N=C1)=O Chemical compound CC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC(C=C2)=CC=C2F)N=C1)=O HWNDZLSNNWFFEJ-SBSPUUFOSA-N 0.000 description 1
- OMJAUIMFWRLBAY-SBSPUUFOSA-N CC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC=CN=C2)N=C1)=O Chemical compound CC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC=CN=C2)N=C1)=O OMJAUIMFWRLBAY-SBSPUUFOSA-N 0.000 description 1
- DVQDRSRXPMVYEC-OGFXRTJISA-N CC1=CC=C(CN2N=CC(C(O)=O)=C2)C=C1.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br Chemical compound CC1=CC=C(CN2N=CC(C(O)=O)=C2)C=C1.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br DVQDRSRXPMVYEC-OGFXRTJISA-N 0.000 description 1
- NQDDPBXCTLBGRZ-DDWIOCJRSA-N CC1=CC=CC(CN2N=CC(C(O)=O)=C2)=C1.COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N Chemical compound CC1=CC=CC(CN2N=CC(C(O)=O)=C2)=C1.COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N NQDDPBXCTLBGRZ-DDWIOCJRSA-N 0.000 description 1
- LFPNOJWVMMWSOD-UHFFFAOYSA-N CN(C)C1CCCN(C1)c1c(Br)cnc2[nH]cc(N)c12 Chemical compound CN(C)C1CCCN(C1)c1c(Br)cnc2[nH]cc(N)c12 LFPNOJWVMMWSOD-UHFFFAOYSA-N 0.000 description 1
- UGLULSBFXMGBTB-UHFFFAOYSA-N CN(C)CC(C=C1)=CC=C1C(C=C12)=CN=C1NC=C2NC(C1=CN(CC2=CC=CC=C2)N=C1)=O.NC(C1=C2)=CNC1=NC=C2C1=CC=C(CN(CC2)CCC2F)C=C1 Chemical compound CN(C)CC(C=C1)=CC=C1C(C=C12)=CN=C1NC=C2NC(C1=CN(CC2=CC=CC=C2)N=C1)=O.NC(C1=C2)=CNC1=NC=C2C1=CC=C(CN(CC2)CCC2F)C=C1 UGLULSBFXMGBTB-UHFFFAOYSA-N 0.000 description 1
- YUVPCMAVSSSYSQ-UHFFFAOYSA-N CN(C)CCCOC(C=C1)=CC=C1C(C=C12)=CN=C1NC=C2NC(C1=CN(CC2=CC=CC=C2)N=C1)=O.CN(CCC1)CC1OC1=CC=CC(C(C=C23)=CN=C2NC=C3N)=C1 Chemical compound CN(C)CCCOC(C=C1)=CC=C1C(C=C12)=CN=C1NC=C2NC(C1=CN(CC2=CC=CC=C2)N=C1)=O.CN(CCC1)CC1OC1=CC=CC(C(C=C23)=CN=C2NC=C3N)=C1 YUVPCMAVSSSYSQ-UHFFFAOYSA-N 0.000 description 1
- LWAFCCQSFGQAQC-UHFFFAOYSA-N CN(C)Cc1ccc(cc1)-c1cnc2[nH]cc(N)c2c1 Chemical compound CN(C)Cc1ccc(cc1)-c1cnc2[nH]cc(N)c2c1 LWAFCCQSFGQAQC-UHFFFAOYSA-N 0.000 description 1
- AOWKUNXVSWMTSM-UHFFFAOYSA-N CN(C)Cc1cccc(c1)-c1cnc2[nH]cc(N)c2c1 Chemical compound CN(C)Cc1cccc(c1)-c1cnc2[nH]cc(N)c2c1 AOWKUNXVSWMTSM-UHFFFAOYSA-N 0.000 description 1
- WFSOVBYUZOGEBY-UHFFFAOYSA-N CNCC(C=C1)=CC=C1C(C=C12)=CN=C1NC=C2N.O=C(C1=CN(CC2=CC=CC=C2)N=C1)NC(C1=C2)=CNC1=NC=C2C1=CC=C(CN2CCOCC2)C=C1 Chemical compound CNCC(C=C1)=CC=C1C(C=C12)=CN=C1NC=C2N.O=C(C1=CN(CC2=CC=CC=C2)N=C1)NC(C1=C2)=CNC1=NC=C2C1=CC=C(CN2CCOCC2)C=C1 WFSOVBYUZOGEBY-UHFFFAOYSA-N 0.000 description 1
- PKOCEBONEXDTFY-UHFFFAOYSA-N CNCc1ccc(cc1)-c1cnc2[nH]cc(N)c2c1 Chemical compound CNCc1ccc(cc1)-c1cnc2[nH]cc(N)c2c1 PKOCEBONEXDTFY-UHFFFAOYSA-N 0.000 description 1
- KKKORGHFBPSQCN-MRVPVSSYSA-N CN[C@@H]1CCCN(C1)c1c(Br)cnc2[nH]cc(N)c12 Chemical compound CN[C@@H]1CCCN(C1)c1c(Br)cnc2[nH]cc(N)c12 KKKORGHFBPSQCN-MRVPVSSYSA-N 0.000 description 1
- PRAUREVGHZSSDV-DDWIOCJRSA-N COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC(C=CC=C2)=C2Cl)N=C1)=O Chemical compound COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC(C=CC=C2)=C2Cl)N=C1)=O PRAUREVGHZSSDV-DDWIOCJRSA-N 0.000 description 1
- MSIWZVCYOPLFBZ-DDWIOCJRSA-N COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC(F)=CC=C2)N=C1)=O Chemical compound COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC(F)=CC=C2)N=C1)=O MSIWZVCYOPLFBZ-DDWIOCJRSA-N 0.000 description 1
- WVVQPKJIHXFHBG-DDWIOCJRSA-N COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O Chemical compound COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O WVVQPKJIHXFHBG-DDWIOCJRSA-N 0.000 description 1
- ZYRXZOXZXSVHIU-DDWIOCJRSA-N COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC=CN=C2)N=C1)=O Chemical compound COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=CC=CN=C2)N=C1)=O ZYRXZOXZXSVHIU-DDWIOCJRSA-N 0.000 description 1
- HZCMGDNELYYKMH-DDWIOCJRSA-N COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=NC=CC=C2)N=C1)=O Chemical compound COC(C(N(CCC1)C[C@@H]1N)=C12)=CN=C1NC=C2N.OC(C1=CN(CC2=NC=CC=C2)N=C1)=O HZCMGDNELYYKMH-DDWIOCJRSA-N 0.000 description 1
- GFXCEZXCSDIYRL-OGFXRTJISA-N COC1=CC=C(CN2N=CC(C(O)=O)=C2)C=C1.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br Chemical compound COC1=CC=C(CN2N=CC(C(O)=O)=C2)C=C1.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br GFXCEZXCSDIYRL-OGFXRTJISA-N 0.000 description 1
- FDZAMAJPQHUQHJ-OGFXRTJISA-N COC1=CC=C(CN2N=CC(C(O)=O)=C2)C=C1.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl Chemical compound COC1=CC=C(CN2N=CC(C(O)=O)=C2)C=C1.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl FDZAMAJPQHUQHJ-OGFXRTJISA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- WHVNAKCUXVQYBR-UNTBIKODSA-N ClC1=CC=C(CN2N=CC(=C2)C(=O)O)C=C1.N[C@H]1CN(CCC1)C1=C2C(=NC=C1Br)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=C(C=C2)F Chemical compound ClC1=CC=C(CN2N=CC(=C2)C(=O)O)C=C1.N[C@H]1CN(CCC1)C1=C2C(=NC=C1Br)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=C(C=C2)F WHVNAKCUXVQYBR-UNTBIKODSA-N 0.000 description 1
- RGKKQRUIVBGXJF-UHFFFAOYSA-N Cn1cc(cn1)-c1cnc2[nH]cc(N)c2c1 Chemical compound Cn1cc(cn1)-c1cnc2[nH]cc(N)c2c1 RGKKQRUIVBGXJF-UHFFFAOYSA-N 0.000 description 1
- 206010053138 Congenital aplastic anaemia Diseases 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 230000007118 DNA alkylation Effects 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 230000012746 DNA damage checkpoint Effects 0.000 description 1
- 239000012623 DNA damaging agent Substances 0.000 description 1
- 230000004543 DNA replication Effects 0.000 description 1
- BWLUMTFWVZZZND-UHFFFAOYSA-N Dibenzylamine Chemical compound C=1C=CC=CC=1CNCC1=CC=CC=C1 BWLUMTFWVZZZND-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- 229910052693 Europium Inorganic materials 0.000 description 1
- KWTYBNKTSQXYLV-GMUIIQOCSA-N FC1=CC=C(CN2N=CC(=C2)C(=O)O)C=C1.N[C@H]1CN(CCC1)C1=C2C(=NC=C1Cl)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=C(C=C2)C Chemical compound FC1=CC=C(CN2N=CC(=C2)C(=O)O)C=C1.N[C@H]1CN(CCC1)C1=C2C(=NC=C1Cl)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=C(C=C2)C KWTYBNKTSQXYLV-GMUIIQOCSA-N 0.000 description 1
- FRFJACSMYUFDEM-FSRHSHDFSA-N FC1=CC=C(CN2N=CC(=C2)C(=O)O)C=C1.N[C@H]1CN(CCC1)C1=C2C(=NC=C1OC)NC=C2NC(=O)C=2C=NN(C2)CC2=C(C=CC=C2)C Chemical compound FC1=CC=C(CN2N=CC(=C2)C(=O)O)C=C1.N[C@H]1CN(CCC1)C1=C2C(=NC=C1OC)NC=C2NC(=O)C=2C=NN(C2)CC2=C(C=CC=C2)C FRFJACSMYUFDEM-FSRHSHDFSA-N 0.000 description 1
- 201000004939 Fanconi anemia Diseases 0.000 description 1
- 230000010337 G2 phase Effects 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 1
- 102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 1
- 102000004457 Granulocyte-Macrophage Colony-Stimulating Factor Human genes 0.000 description 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
- 101000777277 Homo sapiens Serine/threonine-protein kinase Chk2 Proteins 0.000 description 1
- VSNHCAURESNICA-UHFFFAOYSA-N Hydroxyurea Chemical compound NC(=O)NO VSNHCAURESNICA-UHFFFAOYSA-N 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 102000000588 Interleukin-2 Human genes 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019759 Maize starch Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 description 1
- YSGWATGYKAQJOL-UNTBIKODSA-N N1=CC(=CC=C1)CN1N=CC(=C1)C(=O)O.N[C@H]1CN(CCC1)C1=C2C(=NC=C1OC)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=NC=C2 Chemical compound N1=CC(=CC=C1)CN1N=CC(=C1)C(=O)O.N[C@H]1CN(CCC1)C1=C2C(=NC=C1OC)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=NC=C2 YSGWATGYKAQJOL-UNTBIKODSA-N 0.000 description 1
- XGYQOIJLMURDNT-UHFFFAOYSA-N N1=CC=C(C=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2.CN2N=CC(=C2)C=2C=C1C(=NC2)NC=C1NC(=O)C=1C=NN(C1)CC1=CC=CC=C1 Chemical compound N1=CC=C(C=C1)C=1C=C2C(=NC1)NC=C2NC(=O)C=2C=NN(C2)CC2=CC=CC=C2.CN2N=CC(=C2)C=2C=C1C(=NC2)NC=C1NC(=O)C=1C=NN(C1)CC1=CC=CC=C1 XGYQOIJLMURDNT-UHFFFAOYSA-N 0.000 description 1
- 101150081841 NBN gene Proteins 0.000 description 1
- XWRYPFPSCKPQSB-UHFFFAOYSA-N NC(C1=C2)=CNC1=NC=C2C(C=CC(CN1CCCC1)=C1)=C1F.O=C(C1=CN(CC2=CC=CC=C2)N=C1)NC(C1=C2)=CNC1=NC=C2C1=CC(N2CCCC2)=CC=C1 Chemical compound NC(C1=C2)=CNC1=NC=C2C(C=CC(CN1CCCC1)=C1)=C1F.O=C(C1=CN(CC2=CC=CC=C2)N=C1)NC(C1=C2)=CNC1=NC=C2C1=CC(N2CCCC2)=CC=C1 XWRYPFPSCKPQSB-UHFFFAOYSA-N 0.000 description 1
- WDIHOGKPAMVSOE-UHFFFAOYSA-N NC(C1=C2)=CNC1=NC=C2C1=CC(OCCCN2CCOCC2)=CC=C1.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O Chemical compound NC(C1=C2)=CNC1=NC=C2C1=CC(OCCCN2CCOCC2)=CC=C1.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O WDIHOGKPAMVSOE-UHFFFAOYSA-N 0.000 description 1
- LPJBVNBESFYLCN-UHFFFAOYSA-N NC(C1=C2)=CNC1=NC=C2C1=CC(OCCN2CCCC2)=CC=C1.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O Chemical compound NC(C1=C2)=CNC1=NC=C2C1=CC(OCCN2CCCC2)=CC=C1.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O LPJBVNBESFYLCN-UHFFFAOYSA-N 0.000 description 1
- KDJRBWIMFMMRKI-UHFFFAOYSA-N NC(C1=C2)=CNC1=NC=C2C1=CSC(CN2CCCC2)=C1.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O Chemical compound NC(C1=C2)=CNC1=NC=C2C1=CSC(CN2CCCC2)=C1.OC(C1=CN(CC2=CC=CC=C2)N=C1)=O KDJRBWIMFMMRKI-UHFFFAOYSA-N 0.000 description 1
- CKAACKNQKCXNMS-IGLJFSGRSA-N NC(C1=C2N(CC3)C[C@@H]3O)=CNC1=NC=C2Br.O[C@H](CCC1)CN1C1=C(C(NC(C2=CN(CC3=CC=CC=C3)N=C2)=O)=CN2)C2=NC=C1Br Chemical compound NC(C1=C2N(CC3)C[C@@H]3O)=CNC1=NC=C2Br.O[C@H](CCC1)CN1C1=C(C(NC(C2=CN(CC3=CC=CC=C3)N=C2)=O)=CN2)C2=NC=C1Br CKAACKNQKCXNMS-IGLJFSGRSA-N 0.000 description 1
- WYJCJMRFXOGRSK-SSDOTTSWSA-N N[C@@H]1CCCN(C1)c1c(F)cnc2[nH]cc(N)c12 Chemical compound N[C@@H]1CCCN(C1)c1c(F)cnc2[nH]cc(N)c12 WYJCJMRFXOGRSK-SSDOTTSWSA-N 0.000 description 1
- WFXGXSDTSFCUCZ-SSDOTTSWSA-N N[C@@H]1CCCN(C1)c1c(O)cnc2[nH]cc(N)c12 Chemical compound N[C@@H]1CCCN(C1)c1c(O)cnc2[nH]cc(N)c12 WFXGXSDTSFCUCZ-SSDOTTSWSA-N 0.000 description 1
- GWNXSSAWSXFAII-ZCFIWIBFSA-N N[C@@H]1CCN(C1)c1c(Br)cnc2[nH]cc(N)c12 Chemical compound N[C@@H]1CCN(C1)c1c(Br)cnc2[nH]cc(N)c12 GWNXSSAWSXFAII-ZCFIWIBFSA-N 0.000 description 1
- UGDLGCRRLJTBCC-OGFXRTJISA-N N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br.OC(C1=CN(CC2=CC=CN=C2)N=C1)=O Chemical compound N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br.OC(C1=CN(CC2=CC=CN=C2)N=C1)=O UGDLGCRRLJTBCC-OGFXRTJISA-N 0.000 description 1
- QPHJTKCDTAWPQT-OGFXRTJISA-N N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br.OC(C1=CN(CC2=CC=NC=C2)N=C1)=O Chemical compound N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br.OC(C1=CN(CC2=CC=NC=C2)N=C1)=O QPHJTKCDTAWPQT-OGFXRTJISA-N 0.000 description 1
- IFMJQMPEPSQUES-OGFXRTJISA-N N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br.OC(C1=CN(CC2=NC=CC=C2)N=C1)=O Chemical compound N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br.OC(C1=CN(CC2=NC=CC=C2)N=C1)=O IFMJQMPEPSQUES-OGFXRTJISA-N 0.000 description 1
- HIDJJTWMVARPOW-YYVQYPFISA-N N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1C#N.O=C(C1=CN(CC2=CC=CC=C2)N=C1)NC(C1=C2)=CNC1=NC=C2C1=CC(OCCN2CCOCC2)=CC=C1 Chemical compound N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1C#N.O=C(C1=CN(CC2=CC=CC=C2)N=C1)NC(C1=C2)=CNC1=NC=C2C1=CC(OCCN2CCOCC2)=CC=C1 HIDJJTWMVARPOW-YYVQYPFISA-N 0.000 description 1
- ATVHNFUCMKFGOK-OGFXRTJISA-N N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl.OC(C1=CN(CC(C=C2)=CC=C2Cl)N=C1)=O Chemical compound N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl.OC(C1=CN(CC(C=C2)=CC=C2Cl)N=C1)=O ATVHNFUCMKFGOK-OGFXRTJISA-N 0.000 description 1
- WJOWXXHOUGZAOP-OGFXRTJISA-N N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl.OC(C1=CN(CC2=NC=CC=C2)N=C1)=O Chemical compound N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Cl.OC(C1=CN(CC2=NC=CC=C2)N=C1)=O WJOWXXHOUGZAOP-OGFXRTJISA-N 0.000 description 1
- HETFFETWHDPVKB-QEKUCLETSA-N N[C@H](CCC1)CN1C1=C(C(NC(C2=CN(CC3=CC=CC=C3)N=C2)=O)=CN2)C2=NC=C1Cl.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br Chemical compound N[C@H](CCC1)CN1C1=C(C(NC(C2=CN(CC3=CC=CC=C3)N=C2)=O)=CN2)C2=NC=C1Cl.N[C@H](CCC1)CN1C1=C(C(N)=CN2)C2=NC=C1Br HETFFETWHDPVKB-QEKUCLETSA-N 0.000 description 1
- XCQMBHUTTXGWAY-UNTBIKODSA-N N[C@H](CCC1)CN1C1=C(C(NC(C2=CN(CC3=CC=CC=C3)N=C2)=O)=CN2)C2=NC=C1F.NC(C1=C2)=CNC1=NC=C2C1=CC(CN2CCCC2)=CC=C1 Chemical compound N[C@H](CCC1)CN1C1=C(C(NC(C2=CN(CC3=CC=CC=C3)N=C2)=O)=CN2)C2=NC=C1F.NC(C1=C2)=CNC1=NC=C2C1=CC(CN2CCCC2)=CC=C1 XCQMBHUTTXGWAY-UNTBIKODSA-N 0.000 description 1
- HUYFSOSSMCQTEE-SKDRFNHKSA-N N[C@H]1CN(CC[C@@H]1C1CC1)c1c(Br)cnc2[nH]cc(N)c12 Chemical compound N[C@H]1CN(CC[C@@H]1C1CC1)c1c(Br)cnc2[nH]cc(N)c12 HUYFSOSSMCQTEE-SKDRFNHKSA-N 0.000 description 1
- QOMMKHUMIWLGGK-SSDOTTSWSA-N Nc1c[nH]c2ncc(Br)c(N3CCC[C@@H](O)C3)c12 Chemical compound Nc1c[nH]c2ncc(Br)c(N3CCC[C@@H](O)C3)c12 QOMMKHUMIWLGGK-SSDOTTSWSA-N 0.000 description 1
- ZBBVVJLRFQMCIU-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCCC2)cc1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCCC2)cc1 ZBBVVJLRFQMCIU-UHFFFAOYSA-N 0.000 description 1
- VEMXXFAYMSGLHS-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCCC2)cc1F Chemical compound Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCCC2)cc1F VEMXXFAYMSGLHS-UHFFFAOYSA-N 0.000 description 1
- RWZIAHGUGHTSIE-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCCC2)s1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCCC2)s1 RWZIAHGUGHTSIE-UHFFFAOYSA-N 0.000 description 1
- CGGNQVPFTZIXJZ-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCOCC2)cc1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1ccc(CN2CCOCC2)cc1 CGGNQVPFTZIXJZ-UHFFFAOYSA-N 0.000 description 1
- VCBIHBQQXNRKMP-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1cccc(CN2CCCC2)c1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1cccc(CN2CCCC2)c1 VCBIHBQQXNRKMP-UHFFFAOYSA-N 0.000 description 1
- UXNHZYFYYPFIKD-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1cccc(OC2COC2)c1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1cccc(OC2COC2)c1 UXNHZYFYYPFIKD-UHFFFAOYSA-N 0.000 description 1
- WZWLPKXQIBPPDW-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1cccc(OCCCN2CCOCC2)c1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1cccc(OCCCN2CCOCC2)c1 WZWLPKXQIBPPDW-UHFFFAOYSA-N 0.000 description 1
- WWOMLKXHOUOXNN-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)-c1csc(CN2CCCC2)c1 Chemical compound Nc1c[nH]c2ncc(cc12)-c1csc(CN2CCCC2)c1 WWOMLKXHOUOXNN-UHFFFAOYSA-N 0.000 description 1
- OBEYLKAMKXOMHV-UHFFFAOYSA-N Nc1c[nH]c2ncc(cc12)N1CCCCC1 Chemical compound Nc1c[nH]c2ncc(cc12)N1CCCCC1 OBEYLKAMKXOMHV-UHFFFAOYSA-N 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical class O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- KEIXOXQZIIOWQD-UHFFFAOYSA-N OC=1C=C(C=CC=1)C=1C=C2C(=NC=1)N(C=C2NC(=O)C=1C=NN(C=1)CC1=CC=CC=C1)S(=O)(=O)C1=CC=C(C=C1)C Chemical compound OC=1C=C(C=CC=1)C=1C=C2C(=NC=1)N(C=C2NC(=O)C=1C=NN(C=1)CC1=CC=CC=C1)S(=O)(=O)C1=CC=C(C=C1)C KEIXOXQZIIOWQD-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 229930012538 Paclitaxel Natural products 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 102100031075 Serine/threonine-protein kinase Chk2 Human genes 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 239000004141 Sodium laurylsulphate Substances 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 229910052771 Terbium Inorganic materials 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 206010052779 Transplant rejections Diseases 0.000 description 1
- 208000003721 Triple Negative Breast Neoplasms Diseases 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- QFCNHLDVIBPZKC-CYBMUJFWSA-N [4-[(3r)-3-[(2-methylpropan-2-yl)oxycarbonylamino]piperidin-1-yl]-3-nitro-1h-pyrrolo[2,3-b]pyridin-5-yl] 2,2-dimethylpropanoate Chemical compound C1[C@H](NC(=O)OC(C)(C)C)CCCN1C1=C(OC(=O)C(C)(C)C)C=NC2=C1C([N+]([O-])=O)=CN2 QFCNHLDVIBPZKC-CYBMUJFWSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000001780 adrenocortical effect Effects 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 1
- 239000002168 alkylating agent Substances 0.000 description 1
- 229940100198 alkylating agent Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 231100001075 aneuploidy Toxicity 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 229940046836 anti-estrogen Drugs 0.000 description 1
- 230000001833 anti-estrogenic effect Effects 0.000 description 1
- 230000000340 anti-metabolite Effects 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940100197 antimetabolite Drugs 0.000 description 1
- 239000002256 antimetabolite Substances 0.000 description 1
- 229940045686 antimetabolites antineoplastic purine analogs Drugs 0.000 description 1
- 229940045687 antimetabolites folic acid analogs Drugs 0.000 description 1
- 239000003080 antimitotic agent Substances 0.000 description 1
- 229940045719 antineoplastic alkylating agent nitrosoureas Drugs 0.000 description 1
- 229940045688 antineoplastic antimetabolites pyrimidine analogues Drugs 0.000 description 1
- 230000005756 apoptotic signaling Effects 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 125000002393 azetidinyl group Chemical group 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 125000004604 benzisothiazolyl group Chemical group S1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 description 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 description 1
- SGNZKPPDOWTEPS-UHFFFAOYSA-N benzyl 3-azido-4-(4-methylphenyl)sulfonyloxypiperidine-1-carboxylate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC1C(N=[N+]=[N-])CN(C(=O)OCC=2C=CC=CC=2)CC1 SGNZKPPDOWTEPS-UHFFFAOYSA-N 0.000 description 1
- XFFCBJRBTDUAFD-UHFFFAOYSA-N benzyl 4-(diethoxyphosphorylamino)-3-(4-methylphenyl)sulfonyloxypiperidine-1-carboxylate Chemical compound CCOP(=O)(OCC)NC1CCN(C(=O)OCC=2C=CC=CC=2)CC1OS(=O)(=O)C1=CC=C(C)C=C1 XFFCBJRBTDUAFD-UHFFFAOYSA-N 0.000 description 1
- XVIBCNQBYCYALT-UHFFFAOYSA-N benzyl 4-amino-3-(4-methylphenyl)sulfonyloxypiperidine-1-carboxylate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OC1C(N)CCN(C(=O)OCC=2C=CC=CC=2)C1 XVIBCNQBYCYALT-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229960002092 busulfan Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 230000025084 cell cycle arrest Effects 0.000 description 1
- 230000006369 cell cycle progression Effects 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000024321 chromosome segregation Effects 0.000 description 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 description 1
- 229960004316 cisplatin Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 125000006165 cyclic alkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000000640 cyclooctyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- WLVKDFJTYKELLQ-UHFFFAOYSA-N cyclopropylboronic acid Chemical compound OB(O)C1CC1 WLVKDFJTYKELLQ-UHFFFAOYSA-N 0.000 description 1
- 229960000684 cytarabine Drugs 0.000 description 1
- 239000000824 cytostatic agent Substances 0.000 description 1
- 238000011393 cytotoxic chemotherapy Methods 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 229960003901 dacarbazine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- MXFYYFVVIIWKFE-UHFFFAOYSA-N dicyclohexyl-[2-[2,6-di(propan-2-yloxy)phenyl]phenyl]phosphane Chemical group CC(C)OC1=CC=CC(OC(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 MXFYYFVVIIWKFE-UHFFFAOYSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000013024 dilution buffer Substances 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 239000003534 dna topoisomerase inhibitor Substances 0.000 description 1
- 230000005782 double-strand break Effects 0.000 description 1
- 239000000890 drug combination Substances 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 238000000132 electrospray ionisation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 239000000328 estrogen antagonist Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 description 1
- 229960005420 etoposide Drugs 0.000 description 1
- OGPBJKLSAFTDLK-UHFFFAOYSA-N europium atom Chemical compound [Eu] OGPBJKLSAFTDLK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 210000005096 hematological system Anatomy 0.000 description 1
- VHHHONWQHHHLTI-UHFFFAOYSA-N hexachloroethane Chemical compound ClC(Cl)(Cl)C(Cl)(Cl)Cl VHHHONWQHHHLTI-UHFFFAOYSA-N 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 1
- 229960001330 hydroxycarbamide Drugs 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 238000004255 ion exchange chromatography Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 238000013332 literature search Methods 0.000 description 1
- YNESATAKKCNGOF-UHFFFAOYSA-N lithium bis(trimethylsilyl)amide Chemical compound [Li+].C[Si](C)(C)[N-][Si](C)(C)C YNESATAKKCNGOF-UHFFFAOYSA-N 0.000 description 1
- WMFOQBRAJBCJND-UHFFFAOYSA-M lithium hydroxide Inorganic materials [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical class [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 235000012254 magnesium hydroxide Nutrition 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- VFZXMEQGIIWBFJ-UHFFFAOYSA-M magnesium;cyclopropane;bromide Chemical compound [Mg+2].[Br-].C1C[CH-]1 VFZXMEQGIIWBFJ-UHFFFAOYSA-M 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- GQJCAQADCPTHKN-UHFFFAOYSA-N methyl 2,2-difluoro-2-fluorosulfonylacetate Chemical compound COC(=O)C(F)(F)S(F)(=O)=O GQJCAQADCPTHKN-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- KTMKRRPZPWUYKK-UHFFFAOYSA-N methylboronic acid Chemical compound CB(O)O KTMKRRPZPWUYKK-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000017205 mitotic cell cycle checkpoint Effects 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N mono-methylamine Natural products NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- 125000002950 monocyclic group Chemical group 0.000 description 1
- 201000006417 multiple sclerosis Diseases 0.000 description 1
- NMGVIZJUIPNHLI-UHFFFAOYSA-N n,n-dimethylpiperidin-3-amine Chemical group CN(C)C1CCCNC1 NMGVIZJUIPNHLI-UHFFFAOYSA-N 0.000 description 1
- KGAOIYHCFQTRKA-OAHLLOKOSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-2-ylmethyl)pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(C(F)(F)F)C=NC2=C1C(NC(=O)C1=CN(CC=3N=CC=CC=3)N=C1)=CN2 KGAOIYHCFQTRKA-OAHLLOKOSA-N 0.000 description 1
- QTNWUWKATNIWLH-MRXNPFEDSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-(pyridin-3-ylmethyl)pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(C(F)(F)F)C=NC2=C1C(NC(=O)C1=CN(CC=3C=NC=CC=3)N=C1)=CN2 QTNWUWKATNIWLH-MRXNPFEDSA-N 0.000 description 1
- HTOOLTNEQULOQS-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-(trifluoromethyl)-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(4-fluorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(C(F)(F)F)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC(F)=CC=3)N=C1)=CN2 HTOOLTNEQULOQS-QGZVFWFLSA-N 0.000 description 1
- URRSARVIJHLNCX-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(4-chlorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC(Cl)=CC=3)N=C1)=CN2 URRSARVIJHLNCX-QGZVFWFLSA-N 0.000 description 1
- PJDLFZIKISOUET-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(4-fluorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC(F)=CC=3)N=C1)=CN2 PJDLFZIKISOUET-QGZVFWFLSA-N 0.000 description 1
- DQWQPMZVWDESPL-GOSISDBHSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(4-methylphenyl)methyl]pyrazole-4-carboxamide Chemical compound C1=CC(C)=CC=C1CN1N=CC(C(=O)NC=2C3=C(N4C[C@H](N)CCC4)C(Br)=CN=C3NC=2)=C1 DQWQPMZVWDESPL-GOSISDBHSA-N 0.000 description 1
- JYKZGECLJWFYMK-QGZVFWFLSA-N n-[4-[(3r)-3-aminopiperidin-1-yl]-5-chloro-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-[(4-chlorophenyl)methyl]pyrazole-4-carboxamide Chemical compound C1[C@H](N)CCCN1C1=C(Cl)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC(Cl)=CC=3)N=C1)=CN2 JYKZGECLJWFYMK-QGZVFWFLSA-N 0.000 description 1
- GIDXCMOSYBGJED-MRXNPFEDSA-N n-[4-[(3r)-3-aminopyrrolidin-1-yl]-5-bromo-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1[C@H](N)CCN1C1=C(Br)C=NC2=C1C(NC(=O)C1=CN(CC=3C=CC=CC=3)N=C1)=CN2 GIDXCMOSYBGJED-MRXNPFEDSA-N 0.000 description 1
- ISFUPDOATOAKAA-UHFFFAOYSA-N n-[5-[3-(azetidin-1-ylmethyl)phenyl]-1h-pyrrolo[2,3-b]pyridin-3-yl]-1-benzylpyrazole-4-carboxamide Chemical compound C1=NN(CC=2C=CC=CC=2)C=C1C(=O)NC(C1=C2)=CNC1=NC=C2C(C=1)=CC=CC=1CN1CCC1 ISFUPDOATOAKAA-UHFFFAOYSA-N 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 239000002687 nonaqueous vehicle Substances 0.000 description 1
- 239000003956 nonsteroidal anti androgen Substances 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 201000008482 osteoarthritis Diseases 0.000 description 1
- 125000001715 oxadiazolyl group Chemical group 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229960001592 paclitaxel Drugs 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 239000003182 parenteral nutrition solution Substances 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- CHKVPAROMQMJNQ-UHFFFAOYSA-M potassium bisulfate Chemical compound [K+].OS([O-])(=O)=O CHKVPAROMQMJNQ-UHFFFAOYSA-M 0.000 description 1
- 239000001120 potassium sulphate Substances 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- CPTBDICYNRMXFX-UHFFFAOYSA-N procarbazine Chemical compound CNNCC1=CC=C(C(=O)NC(C)C)C=C1 CPTBDICYNRMXFX-UHFFFAOYSA-N 0.000 description 1
- 229960000624 procarbazine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000583 progesterone congener Substances 0.000 description 1
- VVWRJUBEIPHGQF-MDZDMXLPSA-N propan-2-yl (ne)-n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)\N=N\C(=O)OC(C)C VVWRJUBEIPHGQF-MDZDMXLPSA-N 0.000 description 1
- VVWRJUBEIPHGQF-UHFFFAOYSA-N propan-2-yl n-propan-2-yloxycarbonyliminocarbamate Chemical compound CC(C)OC(=O)N=NC(=O)OC(C)C VVWRJUBEIPHGQF-UHFFFAOYSA-N 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 125000000561 purinyl group Chemical class N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- ABMYEXAYWZJVOV-UHFFFAOYSA-N pyridin-3-ylboronic acid Chemical group OB(O)C1=CC=CN=C1 ABMYEXAYWZJVOV-UHFFFAOYSA-N 0.000 description 1
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridine hydrochloride Substances [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- ZSKGQVFRTSEPJT-UHFFFAOYSA-N pyrrole-2-carboxaldehyde Chemical compound O=CC1=CC=CN1 ZSKGQVFRTSEPJT-UHFFFAOYSA-N 0.000 description 1
- 150000005255 pyrrolopyridines Chemical class 0.000 description 1
- 101150010682 rad50 gene Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003362 replicative effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000028617 response to DNA damage stimulus Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N retinoic acid group Chemical class C\C(=C/C(=O)O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 125000006413 ring segment Chemical group 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- WBHQBSYUUJJSRZ-UHFFFAOYSA-M sodium bisulfate Chemical class [Na+].OS([O-])(=O)=O WBHQBSYUUJJSRZ-UHFFFAOYSA-M 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 239000002278 tabletting lubricant Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 1
- NRUKOCRGYNPUPR-QBPJDGROSA-N teniposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@@H](OC[C@H]4O3)C=3SC=CC=3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 NRUKOCRGYNPUPR-QBPJDGROSA-N 0.000 description 1
- 229960001278 teniposide Drugs 0.000 description 1
- GZCRRIHWUXGPOV-UHFFFAOYSA-N terbium atom Chemical compound [Tb] GZCRRIHWUXGPOV-UHFFFAOYSA-N 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YHWGALVHDQPEOA-HXUWFJFHSA-N tert-butyl n-[(3r)-1-[5-bromo-3-[[1-[(4-methoxyphenyl)methyl]pyrazole-4-carbonyl]amino]-1h-pyrrolo[2,3-b]pyridin-4-yl]piperidin-3-yl]carbamate Chemical compound C1=CC(OC)=CC=C1CN1N=CC(C(=O)NC=2C3=C(N4C[C@@H](CCC4)NC(=O)OC(C)(C)C)C(Br)=CN=C3NC=2)=C1 YHWGALVHDQPEOA-HXUWFJFHSA-N 0.000 description 1
- NVISSTNTBKVSPW-SNVBAGLBSA-N tert-butyl n-ethyl-n-[(3r)-piperidin-3-yl]carbamate Chemical group CC(C)(C)OC(=O)N(CC)[C@@H]1CCCNC1 NVISSTNTBKVSPW-SNVBAGLBSA-N 0.000 description 1
- RTXNDTNDOHQMTI-SECBINFHSA-N tert-butyl n-methyl-n-[(3r)-piperidin-3-yl]carbamate Chemical group CC(C)(C)OC(=O)N(C)[C@@H]1CCCNC1 RTXNDTNDOHQMTI-SECBINFHSA-N 0.000 description 1
- 231100001274 therapeutic index Toxicity 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000003396 thiol group Chemical class [H]S* 0.000 description 1
- 125000004568 thiomorpholinyl group Chemical group 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 229940044693 topoisomerase inhibitor Drugs 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000016596 traversing start control point of mitotic cell cycle Effects 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 208000022679 triple-negative breast carcinoma Diseases 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (5)
1H»plrmllopâS»lilpiH«lin«àrroaték#fe ¥siiammt tat kiriázdahibffomlclcénf ¥slé alfcafmaiä« SgÂBASàLMÏ IGÉNYPONTOK
(Ό képlete vegyidet vagy ennek gyogyszerészetiieg elfogadható sója, amely képletben: minden 2 jelentése függetlenül (Aik)P"RP~(Alk)n-Xj ahol minden Alk jelentése függetlenül 1-12 szénatomos alkiSén- vagy 2-12 szénatomos alkenilérvcsöporf. amelyek mindegyike adott esetben ezubsztltuált; minden n jelentése függetlenül 0 vagy 1; minden R jelentése függetlenül adott esetben szubsztifuált arilén- vagy heteroarílén-, vagy adott esetben szubszfltuált cikloalkilén- vagy heterocikíikus csoport, -0-, -S-s -iY>0}~, -(OS)«, -SOr< -0(-0)0-, ~C(«0)NRA-, -C(«S)NRA-, -$02NRA-„ -NRaC(-0;H -NRASOr vagy -TtRÄ- osoport ahol RA jelentése hidrogénatom, 1-i szénatomos alkik 1-i szénatomos alklICoioIoalklI)-, 1-i szénatomos a!kilp-6 szénatomod a lkok!)- vagy 1-6 szénatomos alkoki-qsopert; mindén X felenfése függetlenül balogénatem, -hi, -€>RA, NRARA, adott #siffefn sahsztítnált aril« vagy heieroarltesopert. vagy «sciait esetben szúbsztituált dMoatkíb vagy hetemelkluses csoport, β ΐΐρ CYhalögén)sHb, ahol a értéke 1, 2 vagy 3, és b értéke liNai, Y jelentése adott esetben szúbsztituált ars!» vagy heteroarii-csoport, vagy adott esetben tzubéztituáít eikloalkll· vagy heterociklusos csoport; és ü· jelentése H vagy 1-6 szén atomos alMIc-sopori, azzal a megkötéssel, hogy a vegyüleí nem N"(5<-bróm”4 t]uor~1H~pírro!o|2(3~blplndin'· ^3-ít}>-1^(4^meteklsbeniil}-1 H^plrazoi-44carboxamid vagy (Rjdéro^butibl-iS-ét'dra-ö-li-g4"metoxs^enzil}YH--pir‘azol'4-Yarboxamlct]'-1H-pirrolo[2,3'b]plndin-4aiy'piperldin--3'-ll'· Rtarbamái
2, Egy 1. Igénypont szerinti vegyüiet, amelyben az Y csoport szémára szolgáló opcionális szubsztituenseket az 1~6 szénatomos alkik hidroxi-, bidroxi-CI-l szén-atomos alkll)-, merkapto-·, merkapíö-(t-8 szénatomos afkil)-, (1-6 szénatomos alkil}-tio~csoport: haiogénaíom, trlfluor-metil·, trifluor-metoxh nitro-, nitrit» {-ON}., oxo-, feni-, rooti -cogra. -g©ra -sodr, -cqnhs, -so2nh2, -corhrY -so2nhrâ ~CÖNRaRb. ~SÖsNRaR8, -N%, -NHRa -NRaR8 -0001411¾ -ÖCÖNHR8, -OCÜNRAR8s *MHCÖRa, *NH8CÖÖRa ^AxM)Ra, -MHSGgöRY «sl©2ORA, -NHCOiH?, -NR%ÖNk% -NHCONHR8, ~NRACOMHR, -NHCORRAR8 vagy -NRAÍONRAÍ8 csoportok közül választjuk ki, ahol RA és R8 jelentése függetlenül 1 -6 szénatomos atkítcsoport, vagy RA és R8, akkor amikor ugyanahhoz a nitrogénatom-hoz kapcsolódnak, egy, a nmríghnil·, pipetidinil· vagy a piperazinil-gyürük közül kiválasztott ciklikus aminogyörut képezhetnek, i. Egy 1, vagy 2. igénypont szerinti vegyüiet, amelyben R& jelentése hidrogénatom vagy 1-6 szénatomos aikllcsoport.
4, Az előzői igénypontok egyike szerinti vegyüiet amilyben legalább egy Z Jelentése H. halogénatom, adott esetben szúbsztituált aril·, adott esetben szubszti-tuált heteroan! csoport, adott esetben szúbsztituált nitrogéntartalmú hateroclklus, 1-8 szénatOmns iikiiéseped vagy 0RA csoport. f. Az 1-3. Igénypontok egyike szerinti vegyölet, amelyben legalább egy Z jelentése (Alk);radott esetben szúbsztituált arilén-CARR-adoit esetben szúbsztituált heterociklus, 8* Az efőzi igénypontok egyike szerinti vegyétek ámenben Rí jelentése H és ámélybeh Y jelentése leniiosopnri Ύ, Az előző igénypontok egyike szerinti vegyétek amelynek az alábbi
(la) képlete van, vagy ennek gyogyszefésxeite| elisiiőkalá fője, aÄlybee: lé és Zs jelentése függetlenül (Älk)n~Rfr4Alk}e<X> és Alks n, R, X; % fkAés H' az 1, igénypontban vannak meghatározva 8, A 7. igénypont szerinti vegyidet, amelyben Z< jelentése haíogénatom, fenik vagy 1-6 szénatomos alkilcsoport, és Z* jéliiili# adott esefbén szubsztituált arlk pappert vagy adott esetben szubsztituált heteroeiklus, vagy amelyben Z2 jelentése haíogénatom, CF3> eíklopropik, fenik, OR* vagy 1*6 szénatomos ilkifóaoport és Z5 jelentése adott esetben szubsztituált arilcsoport vagy adott esetben szubsztituált beterociklu#. i, Az előző igénypontok egyike szerinti vegyidet, amelyben a heteroeiklus vagy a nitrogéntartaírnű heteroeiklus egy adott esetben szubszlituáit piperídín, Piperazin vagy moftloíin.
10, Az előző igénypontok egyike szerinti vegyülni amely egyike az alább felsorolt vegyületeknak, vagy ezek gyógyszerészeti leg elfogadható sója; 1^bÍnzik1H*pirazdM^^arbOóSav*p^ferŐrnv1Hvptrrólo|2!3'b]piridin--3-il}'amlct; 1*binzÍI~lH-plrazól*4~karbonsav--(1H*pirroío|;2;3*b]pkidln~3"il)"amid; 1-péiZlk 1 H-pirazol'-4*karbonsav-(4-bróm*1 H-pirrolop^-bjpiridzvo-iij-amld; 1 "benzikl H"pirazok4*karbonsav*(S-feník1 H*pirroio[2t3*b|pindin-3~i!)*amid; vagy 14^rízÍI1iN|pramM»l?ÉTbon§av~{Si3i^rfdlft*1-il*1:H~pirröíöP,3“bílpindín'-3^f|»amid. ^^|44(3R)-3“Ämsn0-plpnd5n-1~I^S«bÄ'1H^irmlöf2i3^lpWin"3''iB''1^«H"1Hi' plmzaM-karbaxamkl 1'4aûZl-1H^!raz0l>4^la^0nsav~|44(R)-3-amPd^lrr0iysn~1:4O*3"brôm-IH-pIfr0!opj-> h]púidtn-34íj-amíd idzaazsM H^ir^#M«kárt>omáf^§^rórB^^:|R)~3~me®|^pín^|íí^f|iím1 ~4|4 U~ pirroio|2 s 3~bjpindin™3'4]'âmki 1 «beazib 1 H^ra20l~4~karbomav-|:6«br0^i?4 -^^~3*eÄ^Äo>f%erÄ** 141)« 1 pirrolopj-blpindin-S'-lli-amld 1r|^^^lH^^szoí^k!a^onsii¥-P«bíé^^4if^|í»3^lá:?oxí~pwúlÍdin~148hiH«· plrral0ps3-ilpiddin~3'ä;)«amsd 1^bépil!il*1H^feôM»kârbon^^l4>rd?ïM-C|^34lPrôxi>pipi
ÔI«>*|~||^k|~ ;pÉraíö|2J"l3|plríd!n«:3''y]''amíd 1«benzlbiy«pPazö^«4''karboasaPÍ5~bró^-4-|3-dlaiaÉ|-am^0rplpdríd^-1-H)«iH- pírrole|l*3*b|^íd<líri3«lljf“'ámid 1'-bfb|li~lH>'P!razdÍ>4-karbonsa¥~p->brédí'44P^$-^§fep®ntl«fTielÍ»adildo)«piperldlp« i«il]«1H^k^d|2s3"b|plrldiri^l^âÂ. l-vbàPsMB-'pima0b4~karbaasa¥-|§'«brirr54-||R)~i~sz0byti!~araÎaa-'Ppabdia-«14!»lH" pkfofpfEJdsJpiÄ^ 1''beazsb1H'-pbazol'-4«karbönsav46'-brófri-44(R><1«(2!2«dsni6f4propH«aaiinD)'-pb>andsrv 1 4|~1 H~pirml0p,3^1plrldia-34i}«amid 1«-benzii4H«piraz0Í«4«'karboaaay«'{S«bróm'-4«[(R)--3~(cikloprop'-bm6tsl'aaisno)“p?p€'ridin«' 14ÍJ-1 B^pkrpiap.S-bJpIridín^SdlI-amid 1~(4~iuof-bpazl!)~1 H»p?raz0W~kaÄnsaV"|4~((B)~3-amto~piperidäa~14l)-5~brÄ-1 H« pirr0lopj-”b|píridíB~3-4!«arnicl 1 ~|4~kláa«banzi!)“1 N-pirazôb4««kafboBsa¥~P"{{R)Aaœia^piipaddin"1-i^3~brèrti4 Η>· pirro lof 2, S«b] pi rid s n~34l]”am id 1 «p-mefibbanzli)«-1H^piraz0l^karb0nsav^p~((l4)'<3“apipp''pperidi?v14|“5#rôm«1 H« ρΐΓφίορ,3·Φ]ρ!^!Π“34|)~ΒΓΒϊΡ 1 ~p~fBab3xbbeazïl)4 H»pirazol-4-karbobaa¥~p~{|R)»3'>araiaö^p3perídsa«14!)-5~braaíí“1 H« pirro!0f2J-'b|pkfdln~34l|«amid l^pkidiB-'idkrnatíbl H«plrazpM“karbaasav44«((l4)-«3'^:bila0^ipandän~1 "k}"l-brdai"iB« pkralop^^ilpkidin-Sdll-abiíd 1 -pirídín~3~il-metíl-1 H~pira2:oí-4~kaít5O:0!eSiv«[4~« pi.rroío[2,3~b]pk id in-3 -il 1-arnid 1~pindin^4^l^mafi^1H~plra^ol'43l«arbopi¥'-[4-'((R)''3'-amino~plpendin-1'3Í)~§^rárp^1H:- pirrolo|'2t3-b|plridln~3"iO"amld N44-í(3R)-3"amino-pipend|n~1 dlj-d-klór-l H-p I rro ΙοΓ2,3- bjpl rid i π -feenzil-1 N- piraz(>!-4-ksrboxamid 144~metl^bβπzi!}“1H«pír¾zolr4-^rteôrlí8av-[4-((R}"3*8mínά^|pÉΓtóferi4^iÄ:N,H* pirrok42s3-b|pi5ridin-3-ilj~amid pírrdíö|23^1P^Hdib~3dil-amy 1~C4^öP&adzil)~1:R'-pif&2öl'4-karbönsav4Mf&}“^Ä pirröiö[2,3~bjpiriÄ4MI]*amid 1-{4-rrmtoxi“beíizl^1 H~piraMW, kad3oasÄ|4-|(Ri»-3-aMto~pppi|lp-|~ll|~6%iir"1 'ip írmí o^:,-34^j^îridiiifi^3~ï j$piddsbMI4lJ*am:id N~{4--f(3R)-3~amm0i#andipz}:díp^k^ 1H »p s razo I -4 ~k a rfeoxa m Id 14»enzjl*1H-pira^r44<ó^«tev^.|(R|^Fp^.^^|M##íÍÉárQ)^1^ pirrslöP^-bJpíddip-S-iO-amii d-benzíH H-pirazak44?atta^^ dl}~S~nÄki~|H- pirroio[2f3-b]piíidin-34iJ-ÉiíM i-benzii'IH'pírazoí^^kárlöPiav-p-lll^-s^^í^pjpgfidin-ldl^b-matikíR^pirfbldP.á- blpirldin-S-nj-arTiid b]plridifv3dPi"amid 1 *benzii~1 H-pzazDl·4-karbonsav~|5~{4^[(2aτιetoxdetil}-meii^·âminö^fmafil}-fensb~1H-pÍrrolo[2;3-'b]piridsn"3dlj'amid l4àênzii-1H»pirâÂôl4^^ôma\^f^^r^j^|w|i^^g)«i;M«pirfôl^jk bjp!fldin~34í]-ar«id p.irro!o[2t3“b]piridln-3‘i!}-amid 1-&&R2ÍM H-pirrolop,!- b]pífídín”34í^aiiisi 143ρη®ί-1Ν-ρΙ^ρ|^^ρΓΡορρ^“{544-(34ί^ΡΡρΙρβΓΐΡ1π·'1-ίΙπΐθίΐΙ}''ίβπΐΙ]-1ΗΙ''ρΐΓΓθ!ο[2(3" I|pddrR»3«il|^mli 1 «PanziPI H-pirafH*pirö!o|2 j-bjprldin-3~HJ~arok1 1 “feibziN Η~ρΐΓ3ζοΙ~4~!<:3ΓΡοπβΒν"[5~(4“ΓηοΓίοΙίΠ'4Ηί"ί^6ϋ!4©ηΙΙ}~1 H-pirroio^, 3~b1 pi ridi n-34i]~amíd 1^#RaâirÂp|mEoM"karbonsâv^5-(4«(3,3^ifluor*pirroi!dip»i;#p|étll')î|iif|*;fH-pirrolo[2,3Hblp:Wdín~3H t-amid: Í-benzif-lH^kazok4'karp©Piav-45-{3-dímefl«aiaiöö«rrietii“fanii}--1H“psríOÍoí2.3· bjpkuiírvS-HJ-arrdd 1»|ρη^»1Η*ρ|ί1ΐ0ί»44<ΡΓ^ΡΡΙ^ν-|^^Ρ^ίϋΡ^Ιρ#Γΐ^Ι^Ι4ΙΛ^^1ί|'^^Ι|“Ι H-pirro!op;3^P|pddin-3-!í}~ar4iÍ 1>?Pinzlk1H#lra40!-4»karfep4S:av-{5“[3-(3 S-dlfiuOPpÍp^flilld-l^rp^tiO^eníll-lH'· pi rro kd 2.. 3-b] púid s n - 3-k}-a m íd 1 lvaπzil·4H-psΓazok4-kaΓbonsav~p'^{3~azetiidiπ~13l'rnefikfen¾ÍV1H-piΓrö]o[2l3'·b!piridîn-3~l!]~amid 1 -benzsM H”p}ra20!-4~karfe0nsa^{5-[343..3“difluor-azetsdin~14í-mefií)~íenji]-1 H-pirTololS^-blpisidin-S-kl-amíd 1 »batókl H~piraz0l^karbonsa¥~[545“pirraNdin~14kmetil4löf©n-24l}»1 H»pirroíd[2,3~ blpírMin-l'-iíl-amid 1-barízIHH-pfrazaM-karbonsa^p^^^^ 4toaíii4!öfea»3dl^1 Η^ρΙίΓοΙερ,Β-' bJplPdín^Hí^arrM 1^βπζΙΙ4Η-ρΪΓ3Ζθ^4^Ρ^ΡΡΡ8ν··{5·|543.3“#ΐΜθΓ-0ζΡϊΡ!0*·ΐΗ|«πιβ1ί!}4ίθίβη··3»Η)-·1Η- pirrolo[2;3~b]psridsn~3~ií}~amid 1 -benzík 1 H-pkazob4-kar'bofMav~[5~(3^irroiliib-1 'ikmetiNfansO-l H-p?fmld|2,3-:fo|piríd1^:3ll-*amM b]pírzíin~34f~arnid l~banzí!»1iE~prazöb4»karbddsav~[4"((R)-3~amibO'pipary|rv14l)-i>%ník1B»pirrölpp,3"· b|pirídin^3dl|~amid t'tenEÍM 1 H~p|ra^Í^ltrbonsav46~Í342~möíf0So^ii~8teí)^nlíj-l H-pírrotepJ- ^plriim“3-4l)-arnísi 14:H;Hiz!l-1H4:MraKOÍ'4'-karbonsav--{54343-dime4il-aminO'212<i?m€ítí(~propoxi)4eníll-'1H·-pirroí0llJ^!píHdíp-3~íl^ami d 1 -beniíN HiÄzpM^rbönsav«{5^3-(3miorMn^^ ΗχρΜο[2,3- b]pirldln~3dí}~am$ 1-£)€3nzi^1Hi\>?razoM~karbonsav4543Hl"?0etil-piperídín~3'-y-ni6íoxi}denÍ!]--1H-· pirrolop^S-bJpirídin-S'-iil-aitiid 1"b8n^b1H-plrazföb4^arbopiav»|S-[34ö)<etán~3dboKl)-fenlf]~ÍH~pírmlo|2y3-b]p^^^^3~ ii}-amíd 1-ba0äl!~1H”pira^db4~kirbobsi^3'i3'<2~pbroiidin'1dbaioxi}"fepi!]-1H^pirrpibi213-' bjpindi?v3~ii}~amki 1--b8:n^b1H^ira^oN-karbonsav-|4^pR!4R|-3''á?nsnO“4”dklopropibpíp8Hdln--14i}“3“ brőm^1IH''pírroio[2P^4^piridin'2kd]-"3mk1 i4ienz^'1H~psrazo^4íarbonsav-{5-(2-'tliior-4-pÍrrDÍidm--1abrnetibfeni|)''1H~pirrofoí2;3·' b]pirídín~3-H]~arYkd 1 dsgnziM H-ptezol-4-kai1bsfísav-p»p«p?rrolsdiú-1 dídenil^l H-pirmícp J-blpirídín~3-i!|~ amid 'ï”bèp^il-1P"pif¾¾ol^kaiκ}n^^iS-(i.m¾atil·1H:“plra^M-í.l)"1H*ípírn^í:öp:,3^ρiíκlí.rï”3” üj-amsd 1-benzibl H-piraz0M~karboaaav-(i-plfidín^4k1 H-pirroió|2,3-b|pírkiib“3-ii}~amld 1 »benzii~1 N~pírazöM~karboaaav~(3~piridin~3^ik1 H-pirroisp j^lpiridia-34i}>-afnid H3~meioxi~benzn)--1 H-i^iraz<d4”karbonsaV'i;6~bróm»1H-pirfoio[2,3~b]piriclin''3Hr;~amsd 1 -<24iuor~b8bZ!l)~1 N~pbagok4~karbönsa¥-f5-bróm H-pkröte[23^!pindin“34i)~ami(l 1 -(2-ciano-benzii}~1 H ~p s razcM-ka rbonsa v~{5~b rom-1 H~psrroio[2,3"b|piridín"3'ii)-aíaid 1~(ÍH'pirrök2di''?b#dí^1^''plrazok4»barbpnaav~:|5-brdm-1H~píYro!o[2J~b}piridin-3~iÍ}-amid 1 »{44iupr-bbpzlí}~1 H“pirazök4~karbonsa^-'(3--brpni'-1 H-pirraipp J<-b|pirídíP^3«?í)-amid l-banzii-l Bmtf4£bl~4»kad3önsay-^^ j-b!pirídib~3"i|xamíd 1 Φβρζί^Ι H-pírazol^karböbsav-p^k!b^1 H~pipoiops 3"b]pf idln-3-í|}~amíd d<4-fiyör^benzíÍ|"iH''pirazbM^kprbonsav-p~kiő:r'd:H~pí:rroÍDpj“b}plbdib~3di)-mniid 1~{3-meföxM5en*íi)~1H“pirazoM~karb0ns8vKS«kióf4^ I^Ppzi^NiMazaU-karban^ I -bmíM bJpJPdlp^df^pld 1 -benzíM H-pimzöM-karbonmv^iil^ááte^terPIho-pí^^fsnill-l H#frroto|2;3~ b)piridin>3-íí}*am.i€l 1^βπζ1Ι>1Η~ρΐΓ32θΜ-Κ8ΓΡοπδ§^$4[:|^^1β1?Ι^Λ.0!#ΙΙ^Ν^ΐΓ§ζ8!ΐ^|«ΙΙΙ^ pirro^o[2f3-bjpiridin-3~ii}"am!d 1 -öenzíb 1 H-pirazol-4-karbonsav-{5-[1-<2"Pírfolidin-1 -ij-etii)-l H-pírazol-4-iíJ-1 H-pirroio!2,3-b]píndin“3”i!}"amid 1 "pindm"4"i!"metH·' 1H- pírazoM~karbonsav'|4»((RV3*arnino-pipendln -1 -üvs-rneioxi-i H» pirroídpy3ib}pii'idin-3»?i]'-amid 1>piHdiM^lafrietii-lH~pira2ol-4~k8fbonsav~[4*(<R)“3~amino~pl.p^iIib4^5^ÂÉ4ll*· pirrolo|2,3»b]pindin-3“ilHifnicí 1 'pirídín*2-il*metiM H>pírazoM-karb©naiv44~({R)^amtop|^ndrri“14í|»S»m0tO3d-1fíá p'írro}ö[2s3~b)pkidín4$4l]*amid 1 -pindMdbfiibbl H~pirazoj^i<8fbonss¥44^{R)~3~afd»^ pirrolpp,3-b|piridin~3'ill~amid 1 -piridin-4-i1~m8tii“1 H-pirazol“4-karbonsav~[44{R)”3-amino-piparsdin-1 dV-S-klór-l H» pirro!o[2,3~b)pindin»3-ííj"amid 1 ^kidin--2dbmptïl“1 H''pirszoM-k3rbonsa4-|4~{{R)~3-arTitoOrpiparidin-4 H~ pinOlo|2t3'b]pifidkv3-il]'arT)ld 1~piridin~4“H“metí!-1H''pirazoM“karbonsav~|4-{(R}-3“aminO’'piperídín-'1“ií)-S''maüi“i;H“ p!rro!o[2,3~b)psrsdín»3'd]-am5d 1“Ρΐπ^ίΠ“34Ι”ΓρρίΗ«1Η^ρί^ζοΙ-4ΐΪϊ^π§8ν^4-{{^'3^πίίΡο^ρβΓ^ίΡ^;4ΪΪ^ΓΤ^Ρ!~ίΗ-· pkrolo[2 ;3*bjpiridirv3»ii!»amid.: 1 -(4-fluôr-benzH)-1 piíTolo[2,3-bJpíndin~3-ilj~amld:: 1·43“mβtîl·bβnzli)«1H~pirazol·44<aÉ^#b^ÉfiP4|^|r'^m^^μP^^I^'“¾ÄS«r¾^^^¾:'^:' pirrolo[2,3-b j p Írjei I n~ 3~ï Ï] -amid 1-(34luor~benzil}3H^iraipb4xkarbon3av~[44{R)'3"abipb"pipérídífvl4|”S4tipíföxb1l4- pirr0Ío[;2;3~b|pkk1kx-3'-H|-amkj pirrelop, 3-bJpirïdin '34l]~amtd 1<SmíiÉ-b^tóí^1H"plrazoM-ksrbor\siiv^^CC^}^^i^ó“pi|3iflÍÍ^*1t:H)-5-ftietöKÍ^ÍH" π-3~ i Ij-amliä: 1~P4|ucsr-fe^rizl^lN"plfáróM~feaffeörísay»|4-{(R^3»am1no~pÍpendln-1~í{}~§4ril1uő^· metMM-pl rroío[2 v3”b|pirsdin»3-il!-amlcl t-heozIH H-piilaob44?arbonsav^|p)-3“amino*p!pérîdin-1 -!Í}~5~trftiörmetíb1 H» :pir?^dpï34>]pl!ld:^3-{^rnid H ^plHd Hrplrsi^plr^-lia-t^ôn sav-f “îi)“5"tfif î ï^0r~ 1 H-p î rrolo^, 3~blplridl n-S - i ll«em îd 1-pirià!p»2-“îbmatlb1 H-pIra|ô;M“karbonsaV"|4^ÇP^3~amino--piperidin‘'1vy}~5~trlfluQr-ípaflblN-pIrrolop^S^bjpirídfp^á'-ilfamid 11 * ^ôgysaæditeiteièny, amely tartalmaz agy
képletö vegyületet vagy ennek egy gyôgyszerèszetiteg elfogadható sóját, amelyben: minden Zj eíentisa függetlenül tAíkJR-i^~(Alk:)írK : ahol minden Alk Jelentése függetlenül 1-12 szénatomos alkilén·· vagy 2-12 szén-atomos alkenilin-óaopoft, amelyek mindegyike adott esetben szubsztituált; minden n jelentése föggebenut t vagy 1 ; minden R |ei«téee %ietlenil edei esetben szubsÂiéft ariiém mÿf vagy adott esetien szubsztifuiJt eitealkilén- vagy heteroclklíkys csoport, -0-% -S-% -fc^úK ^cv, ~cco)ck »€<*s}nr\ -somS -'NR*CC~-ÖK -NRÄSOr vagy -MRÄ- csoport eddi RA jelentése hidrogénatom, 1-6 szénatomos alkih 1-6 szénaiomos alkil{ddloa|ki|^¥; 1-6 Színstomes alkíl{1-0 szén-atomos aikoxi)- vagy 1-6 szénatomod ajkoxbcseport; minden X jelentése Éggetlénöi halogénatom, -ht, -0RÁ; NRARA adott esetben suhszbiuált aril- vagy hateroark-cseport vagy adott esetben szubsztituáit dkloaíklb vagy heterociklusos csoport, CM vagy C(ha!ogén)eHiá* ahol a értéke 1, 2 vagy 3, és b értéke (3~a); f jelentése adott esetben szubsztituált aril- vagy hefsroarl-osoporh vagy adót esetben szubsztituált cíkloalkll- vagy heterociklusos osopoÉf és R ' jelentése H vágy 1-6 szénaicmos alkilcsoport, valamint egy vagy főbb gyogpzarlszetiieg elfogadható hordozót és/vagy kötőanyagot. 12. A 11. Igénypont szerinti gyógyszerkészítmény, amelyben a vegyötet rendelkezik a SRI 0, igénypontok him^slyike szerinti további tulajdonságokkal.
13. Az előző Igénypontok egyike szerinti vegyidet vagy készítmény,, gyógyászatban való alkalmazásra. 14. A 13. igénypont szerinti áíkatmazásfa szolgáló vegyifet, egy, a protein kinéz iktivltás gátlásáért telells körülmény kezelésére, aboi a protein kinéz az CHil, is ábol a körülményt a rák és az: autoimmun rendellenességek közül választ-juk ki. 11. Â 13. igénypont szerinti alkalmazásra szolgáló vagy ulst, ráknak radloterá-piával va|y kemoterápiával kombinációban váló beadással történi kezelésire.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1201566.5A GB201201566D0 (en) | 2012-01-30 | 2012-01-30 | New chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE035332T2 true HUE035332T2 (hu) | 2018-05-02 |
Family
ID=45876325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE13703121A HUE035332T2 (hu) | 2012-01-30 | 2013-01-30 | 1H-pirrollo[2,3-b]piridin-származékok, valamint ezek kináz-inhibitorokként való alkalmazása |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US10000481B2 (hu) |
| EP (1) | EP2809670B1 (hu) |
| JP (1) | JP6199316B2 (hu) |
| CN (4) | CN111484493A (hu) |
| AU (1) | AU2013213954B2 (hu) |
| BR (1) | BR112014018795B1 (hu) |
| CA (1) | CA2862940C (hu) |
| DK (1) | DK2809670T3 (hu) |
| EA (1) | EA026657B1 (hu) |
| ES (1) | ES2637340T3 (hu) |
| GB (1) | GB201201566D0 (hu) |
| HK (1) | HK1200447A1 (hu) |
| HU (1) | HUE035332T2 (hu) |
| IL (1) | IL233595B (hu) |
| IN (1) | IN2014DN06104A (hu) |
| MX (1) | MX352927B (hu) |
| NZ (1) | NZ627361A (hu) |
| PL (1) | PL2809670T3 (hu) |
| PT (1) | PT2809670T (hu) |
| WO (1) | WO2013114113A1 (hu) |
| ZA (1) | ZA201405070B (hu) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201201566D0 (en) * | 2012-01-30 | 2012-03-14 | Vernalis R&D Ltd | New chemical compounds |
| AR090789A1 (es) * | 2012-04-23 | 2014-12-10 | Genentech Inc | Intermediarios y procesos para la preparacion de compuestos |
| KR102325163B1 (ko) * | 2013-08-22 | 2021-11-11 | 제넨테크, 인크. | 화합물의 제조 방법 |
| CN104829609B (zh) * | 2014-02-11 | 2016-08-03 | 北大方正集团有限公司 | 取代的吡啶并嘧啶化合物及其制备方法和应用 |
| MA41559A (fr) * | 2015-09-08 | 2017-12-26 | Taiho Pharmaceutical Co Ltd | Composé de pyrimidine condensé ou un sel de celui-ci |
| US10032914B2 (en) * | 2015-10-20 | 2018-07-24 | Taiwan Semiconductor Manufacturing Co., Ltd. | Semiconductor device and manufacturing method thereof |
| ES2775751T3 (es) | 2016-02-23 | 2020-07-28 | Taiho Pharmaceutical Co Ltd | Nuevo compuesto de pirimidina condensada o sal del mismo |
| JP7033143B2 (ja) | 2017-08-21 | 2022-03-09 | 大鵬薬品工業株式会社 | Dctn1タンパク質とretタンパク質との融合タンパク質 |
| TW202043198A (zh) | 2019-01-17 | 2020-12-01 | 美商Ifm Due有限公司 | 用於治療與sting活性相關之病況的化合物及組合物 |
| CN111518096B (zh) | 2019-02-02 | 2022-02-11 | 江苏威凯尔医药科技有限公司 | 两面神激酶jak家族抑制剂及其制备和应用 |
| US12428395B2 (en) | 2019-08-01 | 2025-09-30 | Sperogenix Therapeutics Limited | Heterocyclic compounds as kinase inhibitor and uses thereof |
| IT202000005527A1 (it) * | 2020-03-16 | 2021-09-16 | Univ Degli Studi Di Trento | Trattamento terapeutico di cromatinopatie |
| PY2157405A (es) * | 2020-07-15 | 2022-04-22 | Ifm Due Inc | Compuestos y composiciones para el tratamiento de afecciones asociadas a la actividad del sting |
| EP4182030A1 (en) * | 2020-07-15 | 2023-05-24 | IFM Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| EP4182310A1 (en) | 2020-07-15 | 2023-05-24 | IFM Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| TW202235073A (zh) | 2021-01-08 | 2022-09-16 | 美商Ifm Due有限公司 | 用於治療與sting活性相關的病狀之化合物及組合物 |
| UY39892A (es) | 2021-08-10 | 2023-03-31 | Novartis Pharma Ag | Compuestos y composiciones para tratar afecciones asociadas con la actividad de STING |
| WO2023137034A1 (en) * | 2022-01-12 | 2023-07-20 | Ifm Due, Inc. | Compounds and compositions for treating conditions associated with sting activity |
| CN116554170A (zh) * | 2023-04-26 | 2023-08-08 | 上海大学 | 4-氟-7-氮杂吲哚的制备方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1012976A (en) * | 1909-03-25 | 1911-12-26 | Adolf Bordt | Adding-machine. |
| WO2003028724A1 (en) | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
| US7531553B2 (en) * | 2003-03-21 | 2009-05-12 | Amgen Inc. | Heterocyclic compounds and methods of use |
| CA2546754A1 (en) * | 2003-11-21 | 2005-06-09 | Array Biopharma Inc. | Akt protein kinase inhibitors |
| US8841304B2 (en) * | 2008-01-08 | 2014-09-23 | Array Biopharma, Inc. | Pyrrolopyridines as kinase inhibitors |
| DK2294065T3 (da) * | 2008-01-22 | 2014-04-28 | Vernalis R&D Ltd | Indolyl-pyridonderivater med checkpoint kinase 1 inhibitorisk aktivitet |
| AR071717A1 (es) * | 2008-05-13 | 2010-07-07 | Array Biopharma Inc | Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer. |
| BRPI0909957A2 (pt) | 2008-06-11 | 2016-04-19 | Genentech Inc | "composto, composição farmacêutica, método de inibir o crescimento anormal de células ou de tratar um distúrbio hiperproliferativo em um mamífero, método de tratamento do câncer em um mamífero" |
| EP2461869B1 (en) * | 2009-08-06 | 2013-08-21 | Merck Patent GmbH | Novel bicyclic urea compounds |
| WO2011146313A1 (en) * | 2010-05-19 | 2011-11-24 | The University Of North Carolina At Chapel Hill | Pyrazolopyrimidine compounds for the treatment of cancer |
| GB201201566D0 (en) * | 2012-01-30 | 2012-03-14 | Vernalis R&D Ltd | New chemical compounds |
-
2012
- 2012-01-30 GB GBGB1201566.5A patent/GB201201566D0/en not_active Ceased
-
2013
- 2013-01-30 DK DK13703121.7T patent/DK2809670T3/en active
- 2013-01-30 PT PT137031217T patent/PT2809670T/pt unknown
- 2013-01-30 PL PL13703121T patent/PL2809670T3/pl unknown
- 2013-01-30 CN CN202010405942.3A patent/CN111484493A/zh active Pending
- 2013-01-30 US US14/375,353 patent/US10000481B2/en active Active
- 2013-01-30 EP EP13703121.7A patent/EP2809670B1/en active Active
- 2013-01-30 CA CA2862940A patent/CA2862940C/en active Active
- 2013-01-30 CN CN201380014717.5A patent/CN104203948A/zh active Pending
- 2013-01-30 EA EA201491376A patent/EA026657B1/ru not_active IP Right Cessation
- 2013-01-30 NZ NZ627361A patent/NZ627361A/en not_active IP Right Cessation
- 2013-01-30 HU HUE13703121A patent/HUE035332T2/hu unknown
- 2013-01-30 HK HK15100794.1A patent/HK1200447A1/xx unknown
- 2013-01-30 IN IN6104DEN2014 patent/IN2014DN06104A/en unknown
- 2013-01-30 WO PCT/GB2013/050212 patent/WO2013114113A1/en not_active Ceased
- 2013-01-30 JP JP2014555310A patent/JP6199316B2/ja not_active Expired - Fee Related
- 2013-01-30 BR BR112014018795-9A patent/BR112014018795B1/pt not_active IP Right Cessation
- 2013-01-30 CN CN201610920724.7A patent/CN107011341A/zh active Pending
- 2013-01-30 CN CN201610920720.9A patent/CN106866658B/zh not_active Expired - Fee Related
- 2013-01-30 MX MX2014009112A patent/MX352927B/es active IP Right Grant
- 2013-01-30 ES ES13703121.7T patent/ES2637340T3/es active Active
- 2013-01-30 AU AU2013213954A patent/AU2013213954B2/en active Active
-
2014
- 2014-07-10 IL IL233595A patent/IL233595B/en active IP Right Grant
- 2014-07-11 ZA ZA2014/05070A patent/ZA201405070B/en unknown
-
2018
- 2018-06-15 US US16/009,439 patent/US10889582B2/en active Active
-
2020
- 2020-11-30 US US17/107,176 patent/US20210206762A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2809670T3 (en) | 1H-PYRROLO [2,3-B] PYRIDINE DERIVATIVES AND THEIR USE AS KINASE INHIBITORS | |
| JP7051829B2 (ja) | Dnmt1の阻害剤としての置換ピリジン | |
| CN104781255B (zh) | 作为trka激酶抑制剂的n‑吡咯烷基、n’‑吡唑基‑脲、硫脲、胍和氰基胍化合物 | |
| CN102307870B (zh) | Vegf-r2的吡啶氧基吲哚类抑制剂及其用于治疗疾病的用途 | |
| CN106999479B (zh) | 可用作sumo活化酶抑制剂的杂芳基化合物 | |
| CN102015693B (zh) | 作为erk抑制剂的化合物 | |
| JP2022500368A (ja) | 急速進行性線維肉腫ポリペプチドの標的分解のための多環式化合物および方法 | |
| CN111601799A (zh) | 作为Il-17调节剂的稠合咪唑衍生物 | |
| CN107635986A (zh) | 取代的喹喔啉衍生物 | |
| JP2014508801A (ja) | 置換された縮合三環式化合物、その組成物および医学的応用 | |
| NZ586756A (en) | Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity | |
| WO2020098720A1 (zh) | 一类五元并六元杂环化合物及其作为蛋白受体激酶抑制剂的用途 | |
| CN111670183A (zh) | 作为cdk8/19抑制剂的新型杂环化合物 | |
| WO2023174406A1 (zh) | 含氮杂环类衍生物抑制剂、其制备方法和应用 | |
| WO2021121390A1 (zh) | 杂环化合物及其药物组合物、制备方法、中间体和应用 | |
| WO2021249417A1 (zh) | 杂环化合物及其衍生物 | |
| HK1240217B (zh) | 1h-吡咯并[2,3-b]吡啶衍生物及它们作为激酶抑制剂的用途 | |
| HK40025567A (en) | 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors | |
| HK1240217A1 (en) | 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors | |
| HK1240227A1 (en) | 1h-pyrrolo[2,3-b] pyridine derivatives and their use as kinase inhibitors | |
| WO2022028556A1 (zh) | Cdk9抑制剂及其用途 | |
| EA047095B1 (ru) | Соединение, обладающее ингибирующей активностью в отношении brd4, способ его получения и его применения |